www.empr.com Open in urlscan Pro
3.225.154.29 Public Scan

Go To Rescan
Add Verdict Report

Submitted URL:
http://link.email.empr.com/a/1323/click/65947/2303653/542902fc477add73eb37b498d8333dad5d00c2d6/b8c97b8721167c001d1643c6fe14...
Effective URL:
https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-...
Submission: On August 26 via api (August 26th 2019, 4:31:49 am UTC) from US

Summary HTTP 211 Redirects Links 34 Behaviour Indicators

Summary

This website contacted 31 IPs in 6 countries across 29 domains to perform 211 HTTP transactions. The main IP is 3.225.154.29, located in Ashburn, United States and belongs to AMAZON-AES - Amazon.com, Inc., US. The main domain is www.empr.com.
TLS certificate: Issued by RapidSSL RSA CA 2018 on January 16th 2019. Valid for: 2 years.

This is the only time www.empr.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
1 1	35.238.92.4 35.238.92.4	15169 (GOOGLE) (GOOGLE - Google LLC)
35	3.225.154.29 3.225.154.29	14618 (AMAZON-AES) (AMAZON-AES - Amazon.com)
24	94.31.29.64 94.31.29.64	33438 (HIGHWINDS2) (HIGHWINDS2 - Highwinds Network Group)
3	2a00:1450:400... 2a00:1450:4001:81f::200a	15169 (GOOGLE) (GOOGLE - Google LLC)
1	93.184.220.113 93.184.220.113	15133 (EDGECAST) (EDGECAST - MCI Communications Services)
6	2a00:1450:400... 2a00:1450:4001:818::2002	15169 (GOOGLE) (GOOGLE - Google LLC)
4	52.216.206.253 52.216.206.253	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
1	2a00:1450:400... 2a00:1450:4001:81a::2008	15169 (GOOGLE) (GOOGLE - Google LLC)
1	2600:9000:205... 2600:9000:2057:5c00:1b:fadc:b780:93a1	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
1	2a00:1450:400... 2a00:1450:4001:808::2002	15169 (GOOGLE) (GOOGLE - Google LLC)
9	216.58.207.34 216.58.207.34	15169 (GOOGLE) (GOOGLE - Google LLC)
1	2606:4700::68... 2606:4700::6813:9308	13335 (CLOUDFLAR...) (CLOUDFLARENET - Cloudflare)
3 6	2a00:1450:400... 2a00:1450:4001:81a::200e	15169 (GOOGLE) (GOOGLE - Google LLC)
1 3	104.111.214.103 104.111.214.103	16625 (AKAMAI-AS) (AKAMAI-AS - Akamai Technologies)
5	2a00:1450:400... 2a00:1450:4001:816::2003	15169 (GOOGLE) (GOOGLE - Google LLC)
67	2606:4700:20:... 2606:4700:20::6819:5365	13335 (CLOUDFLAR...) (CLOUDFLARENET - Cloudflare)
1	35.174.96.0 35.174.96.0	14618 (AMAZON-AES) (AMAZON-AES - Amazon.com)
3	2a03:2880:f01... 2a03:2880:f01c:8012:face:b00c:0:3	32934 (FACEBOOK) (FACEBOOK - Facebook)
2 2	2a00:1450:400... 2a00:1450:400c:c00::9b	15169 (GOOGLE) (GOOGLE - Google LLC)
3 4	2a00:1450:400... 2a00:1450:4001:820::2004	15169 (GOOGLE) (GOOGLE - Google LLC)
2	2a00:1450:400... 2a00:1450:4001:821::2003	15169 (GOOGLE) (GOOGLE - Google LLC)
3	2a03:2880:f11... 2a03:2880:f11c:8083:face:b00c:0:25de	32934 (FACEBOOK) (FACEBOOK - Facebook)
2	35.227.192.113 35.227.192.113	15169 (GOOGLE) (GOOGLE - Google LLC)
6	2a00:1450:400... 2a00:1450:4001:806::2001	15169 (GOOGLE) (GOOGLE - Google LLC)
3	2600:1f14:e96... 2600:1f14:e96:5800:e914:8d8d:e7fd:f63e	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
4	2600:9000:205... 2600:9000:2057:1e00:16:bc48:4dc0:93a1	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
2 6	2600:1f14:e96... 2600:1f14:e96:5800:bf44:2e7b:f554:ed7b	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
1 3	2600:1f14:e96... 2600:1f14:e96:5802:dbba:9f1a:1862:a442	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
2	54.218.116.18 54.218.116.18	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
1	34.210.86.189 34.210.86.189	16509 (AMAZON-02) (AMAZON-02 - Amazon.com)
3	216.58.207.66 216.58.207.66	15169 (GOOGLE) (GOOGLE - Google LLC)
1 1	2a00:1450:400... 2a00:1450:400c:c00::9a	15169 (GOOGLE) (GOOGLE - Google LLC)
1	2a00:1450:400... 2a00:1450:4001:81d::2003	15169 (GOOGLE) (GOOGLE - Google LLC)
211	31

1 35.238.92.4 (United States) 1 redirects

ASN15169 (GOOGLE - Google LLC, US)
PTR: 4.92.238.35.bc.googleusercontent.com

link.email.empr.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

35 3.225.154.29 (Ashburn, United States)

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-3-225-154-29.compute-1.amazonaws.com

www.empr.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
www.infectiousdiseaseadvisor.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
www.endocrinologyadvisor.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

24 94.31.29.64 (United Kingdom)

ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US)
PTR: 94.31.29.64.IPYX-077437-ZYO.above.net

1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a00:1450:4001:81f::200a (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

fonts.googleapis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 93.184.220.113 (London, United Kingdom)

ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US)

tags.crwdcntrl.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 2a00:1450:4001:818::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

www.googletagservices.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
adservice.google.de	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 52.216.206.253 (Ashburn, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: s3-1.amazonaws.com

s3.amazonaws.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:81a::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2600:9000:2057:5c00:1b:fadc:b780:93a1 (United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)

content.maropost.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:808::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

adservice.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

9 216.58.207.34 (Mountain View, United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: fra16s24-in-f2.1e100.net

securepubads.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700::6813:9308 (United States)

ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US)

script.crazyegg.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 2a00:1450:4001:81a::200e (Frankfurt am Main, Germany) 3 redirects

ASN15169 (GOOGLE - Google LLC, US)

www.google-analytics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 104.111.214.103 (Netherlands) 1 redirects

ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US)
PTR: a104-111-214-103.deploy.static.akamaitechnologies.com

sb.scorecardresearch.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 2a00:1450:4001:816::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

fonts.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

67 2606:4700:20::6819:5365 (United States)

ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US)

c.lytics.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 35.174.96.0 (Ashburn, United States)

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-35-174-96-0.compute-1.amazonaws.com

accounts.haymarketmedia.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a03:2880:f01c:8012:face:b00c:0:3 (Ireland)

ASN32934 (FACEBOOK - Facebook, Inc., US)

connect.facebook.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:400c:c00::9b (Brussels, Belgium) 2 redirects

ASN15169 (GOOGLE - Google LLC, US)

stats.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2a00:1450:4001:820::2004 (Frankfurt am Main, Germany) 3 redirects

ASN15169 (GOOGLE - Google LLC, US)

www.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:821::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

www.google.de	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a03:2880:f11c:8083:face:b00c:0:25de (Ireland)

ASN32934 (FACEBOOK - Facebook, Inc., US)

www.facebook.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 35.227.192.113 (Mountain View, United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: 113.192.227.35.bc.googleusercontent.com

api.lytics.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 2a00:1450:4001:806::2001 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

tpc.googlesyndication.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2600:1f14:e96:5800:e914:8d8d:e7fd:f63e (Boardman, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)

api.b2c.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2600:9000:2057:1e00:16:bc48:4dc0:93a1 (United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)

adtrackapi.haymarketmedia.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 2600:1f14:e96:5800:bf44:2e7b:f554:ed7b (Boardman, United States) 2 redirects

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)

api-54-218-116-18.b2c.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2600:1f14:e96:5802:dbba:9f1a:1862:a442 (Boardman, United States) 1 redirects

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)

api-34-210-86-189.b2c.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 54.218.116.18 (Boardman, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-54-218-116-18.us-west-2.compute.amazonaws.com

api-54-218-116-18.b2c.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 34.210.86.189 (Boardman, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-34-210-86-189.us-west-2.compute.amazonaws.com

api-34-210-86-189.b2c.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 216.58.207.66 (Mountain View, United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: fra16s25-in-f2.1e100.net

pagead2.googlesyndication.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:400c:c00::9a (Brussels, Belgium) 1 redirects

ASN15169 (GOOGLE - Google LLC, US)

stats.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:81d::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)

www.google.de	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
69	lytics.io c.lytics.io api.lytics.io	85 KB
34	empr.com 1 redirects link.email.empr.com www.empr.com	3 MB
24	netdna-ssl.com 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com	257 KB
15	b2c.com 3 redirects api.b2c.com api-54-218-116-18.b2c.com api-34-210-86-189.b2c.com	20 KB
12	doubleclick.net 3 redirects securepubads.g.doubleclick.net stats.g.doubleclick.net	104 KB
9	googlesyndication.com tpc.googlesyndication.com Failed pagead2.googlesyndication.com	155 KB
6	google-analytics.com 3 redirects www.google-analytics.com	40 KB
5	haymarketmedia.com accounts.haymarketmedia.com subapi.haymarketmedia.com Failed adtrackapi.haymarketmedia.com	2 KB
5	gstatic.com fonts.gstatic.com	65 KB
5	google.com 3 redirects adservice.google.com www.google.com	710 B
5	googletagservices.com www.googletagservices.com	124 KB
4	google.de adservice.google.de www.google.de	498 B
4	amazonaws.com s3.amazonaws.com	2 MB
3	facebook.com www.facebook.com	250 B
3	facebook.net connect.facebook.net	102 KB
3	scorecardresearch.com 1 redirects sb.scorecardresearch.com	3 KB
3	googleapis.com fonts.googleapis.com	2 KB
1	endocrinologyadvisor.com www.endocrinologyadvisor.com	649 KB
1	infectiousdiseaseadvisor.com www.infectiousdiseaseadvisor.com	42 KB
1	crazyegg.com script.crazyegg.com	28 KB
1	maropost.com content.maropost.com mpct1.maropost.com Failed	3 KB
1	googletagmanager.com www.googletagmanager.com	34 KB
1	crwdcntrl.net tags.crwdcntrl.net	11 KB
0	spotible.com Failed ads.spotible.com Failed
0	adsrvr.org Failed js.adsrvr.org Failed
0	sitomobile.com Failed mt.sitomobile.com Failed
0	cloudfront.net Failed d31qbv1cthcecs.cloudfront.net Failed
0	ml314.com Failed ml314.com Failed
0	medtargetsystem.com Failed www.medtargetsystem.com Failed
211	29

	Domain	Requested by
67	c.lytics.io	1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com c.lytics.io www.empr.com
33	www.empr.com	www.empr.com 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
24	1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com	www.empr.com 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
9	securepubads.g.doubleclick.net	www.googletagservices.com securepubads.g.doubleclick.net www.empr.com
8	api-54-218-116-18.b2c.com	2 redirects www.empr.com
6	tpc.googlesyndication.com	securepubads.g.doubleclick.net
6	www.google-analytics.com	3 redirects www.googletagmanager.com www.google-analytics.com
5	fonts.gstatic.com	www.empr.com 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
5	www.googletagservices.com	www.empr.com securepubads.g.doubleclick.net
4	api-34-210-86-189.b2c.com	1 redirects www.empr.com
4	adtrackapi.haymarketmedia.com	s3.amazonaws.com
4	www.google.com	3 redirects securepubads.g.doubleclick.net
4	s3.amazonaws.com	www.empr.com
3	pagead2.googlesyndication.com	www.empr.com
3	api.b2c.com	securepubads.g.doubleclick.net
3	www.facebook.com	www.empr.com connect.facebook.net
3	www.google.de	www.empr.com
3	stats.g.doubleclick.net	3 redirects
3	connect.facebook.net	www.empr.com connect.facebook.net
3	sb.scorecardresearch.com	1 redirects www.empr.com www.googletagmanager.com
3	fonts.googleapis.com	www.empr.com s3.amazonaws.com
2	api.lytics.io	c.lytics.io 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
1	www.endocrinologyadvisor.com	www.empr.com
1	www.infectiousdiseaseadvisor.com	www.empr.com
1	accounts.haymarketmedia.com	1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
1	script.crazyegg.com	www.googletagmanager.com
1	adservice.google.com	www.googletagservices.com
1	adservice.google.de	www.googletagservices.com
1	content.maropost.com	www.empr.com
1	www.googletagmanager.com	www.empr.com
1	tags.crwdcntrl.net	www.empr.com
1	link.email.empr.com	1 redirects
0	ads.spotible.com Failed	www.empr.com
0	subapi.haymarketmedia.com Failed	s3.amazonaws.com
0	js.adsrvr.org Failed	www.googletagmanager.com
0	mt.sitomobile.com Failed	www.googletagmanager.com
0	d31qbv1cthcecs.cloudfront.net Failed	www.empr.com
0	ml314.com Failed	www.empr.com
0	www.medtargetsystem.com Failed	www.empr.com
0	mpct1.maropost.com Failed	content.maropost.com
211	40

This site contains links to these domains. Also see Links.

Domain
subscribe.haymarketmedia.com
www.facebook.com
twitter.com
www.linkedin.com
productdirectory.empr.com
jobs.empr.com
reddit.com
www.vrtx.com
www.cancertherapyadvisor.com
www.clinicaladvisor.com
www.clinicalpainadvisor.com
www.dermatologyadvisor.com
www.endocrinologyadvisor.com
www.gastroenterologyadvisor.com
www.hematologyadvisor.com
www.infectiousdiseaseadvisor.com
www.mcknights.com
www.mcknightsseniorliving.com
www.medicalbag.com
www.mycme.com
www.neurologyadvisor.com
www.oncologynurseadvisor.com
www.psychiatryadvisor.com
www.pulmonologyadvisor.com
www.renalandurologynews.com
www.rheumatologyadvisor.com
www.thecardiologyadvisor.com
haymarketmediaus.com

Subject Issuer	Validity	Valid
*.empr.com RapidSSL RSA CA 2018	`2019-01-16` - `2021-01-15`	2 years	crt.sh
*.netdna-ssl.com Sectigo RSA Domain Validation Secure Server CA	`2019-02-18` - `2020-02-27`	a year	crt.sh
*.googleapis.com Google Internet Authority G3	`2019-07-29` - `2019-10-21`	3 months	crt.sh
tags.crwdcntrl.net DigiCert SHA2 Secure Server CA	`2019-03-15` - `2021-04-07`	2 years	crt.sh
*.g.doubleclick.net Google Internet Authority G3	`2019-07-29` - `2019-10-21`	3 months	crt.sh
s3.amazonaws.com DigiCert Baltimore CA-2 G2	`2018-12-03` - `2019-10-25`	a year	crt.sh
*.google-analytics.com Google Internet Authority G3	`2019-07-29` - `2019-10-21`	3 months	crt.sh
content.maropost.com Amazon	`2018-10-25` - `2019-11-25`	a year	crt.sh
*.google.com Google Internet Authority G3	`2019-07-29` - `2019-10-21`	3 months	crt.sh
ssl945600.cloudflaressl.com COMODO ECC Domain Validation Secure Server CA 2	`2019-08-20` - `2020-02-26`	6 months	crt.sh
*.scorecardresearch.com COMODO RSA Organization Validation Secure Server CA	`2018-11-28` - `2019-12-26`	a year	crt.sh
ssl379818.cloudflaressl.com COMODO ECC Domain Validation Secure Server CA 2	`2019-07-26` - `2020-02-01`	6 months	crt.sh
accounts.haymarketmedia.com Amazon	`2018-10-26` - `2019-11-26`	a year	crt.sh
*.facebook.com DigiCert SHA2 High Assurance Server CA	`2019-06-06` - `2019-09-04`	3 months	crt.sh
www.google.de Google Internet Authority G3	`2019-07-29` - `2019-10-21`	3 months	crt.sh
*.lytics.io RapidSSL TLS RSA CA G1	`2018-01-26` - `2020-01-06`	2 years	crt.sh
*.infectiousdiseaseadvisor.com RapidSSL RSA CA 2018	`2019-02-20` - `2020-02-20`	a year	crt.sh
*.endocrinologyadvisor.com RapidSSL RSA CA 2018	`2019-01-23` - `2020-01-23`	a year	crt.sh
tpc.googlesyndication.com Google Internet Authority G3	`2019-07-29` - `2019-10-21`	3 months	crt.sh
*.b2c.com Amazon	`2019-03-24` - `2020-04-24`	a year	crt.sh
adtrackapi.haymarketmedia.com Amazon	`2019-03-27` - `2020-04-27`	a year	crt.sh
www.google.com Google Internet Authority G3	`2019-07-29` - `2019-10-21`	3 months	crt.sh

This page contains 8 frames:

Primary Page: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Frame ID: ED6B69E7BE60289DDAE910EABCE7D815
Requests: 182 HTTP requests in this frame

Frame: https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/8da70cfbeb5a180f6aa334afaaa4cf63?segments=true&mergestate=true&ts=1566793876588
Frame ID: FE17EED0BB0FC09BBF3E695C6242B77E
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: FDC184D99DFC31DF64CDFF4FC79D634B
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 07A9B4045FED033AF53B29602075CE47
Requests: 1 HTTP requests in this frame

Frame: https://ads.spotible.com/tag/universal-tag.js
Frame ID: A22F016EF0F8F1E1C3F215EBE80E768C
Requests: 2 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstNZUe6Vwj3iAXiTGDsMCw4XTJUBf7hrkTucM_P3dC6zQqlZwiy3Cs0ADuJKFijKRu-UKN2DVWxR5NU3HYBAlT725hSzcdtu8pto0nDvlQucfh_lL5a0dBkTvA82oqs5aVUxUJg7lCUiHkzfZ0ESxDVj5R_WHf2VT-OhISDJdMwqZvvbWkPWGxNTxAIL5Uq3-_0xytuDG-7JzV4ILT-7pQZhewi0clwERnHRMCdKAx9eQYAytv9kE7rRqvpjxqy4w9QQlxZ7d3D87Wez06W9g2UI2bXO7pFCaZ7DZPcHlWsIOTnpSenTYc&sig=Cg0ArKJSzEnlymmOeD0VEAE&adurl=
Frame ID: B3E00E2E14A1DC4A65C1ACF31402109B
Requests: 10 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjss3X9IWLbI6iBf0vEBVyOES0vd5rHvSdWDP-oeAQNg99AkvT8zmeY1PLYvjjne5c7ml5WK-8Ws8b0eYhCtKcS8-23QZwlCxuom5FiiHDGj5UiRQtdltur3Aac_CCrLPyZR-Q3Kymq0gA-itr4YdZddYyLzfnK5K7NDfP_wgvgjpOj5gNR0JVgYS33QxGEhUVEVE166Ka0vgb4K10locmKY034DiUIUkjbeT48zMtmrVew9bpyDNLVh4j4GXDKVfcYhhx2A5k0sgnzUfMbEqw0XpsBbsLWZrQCtfKwnibHU&sai=AMfl-YQV04f8agt5z-ZyljET_4GYnlv-YzzkxNBJtrjM2fP24rk9BI1YxXlJA6HmFZJVrv6dLoj924Mu5O2v96p5N_gmXMYhVSb9i4oIE7u2&sig=Cg0ArKJSzHxbqYB20tXVEAE&adurl=
Frame ID: BDFE322DB08A503914C4BC62DC312674
Requests: 10 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsskNEukyTeFb-_aUW2PnZrLM4yLREUAgnyW90lk3nozX339R9yXuGLQGgUsXgJ4atk0sOr9AXW7Tb7HtmCjTGNoK5ad7z1AsIKywmtJFa0yCfYV25P0CjUuoOQS2aeHGXUOQ-dGXhv2WOUHdlgyCBcx4XMC1xuHRzd7rE2_vj0CGYNd8CoshO856LImf9zi9yluvz-dfw6fzBQvi2dyxc6wupr1s45MNBjvH-UV-O3bggxTn2XassCN2uIGjVCR4UrFNhRg7MPAY9jaXtFxElwTqgy6NC-hVgd6IuH76qw&sig=Cg0ArKJSzFl3CMdrDeueEAE&adurl=
Frame ID: 3EE95A9CEC98C3F0F9A398F3271DB40A
Requests: 11 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page URL History Show full URLs

http://link.email.empr.com/a/1323/click/65947/2303653/542902fc477add73eb37b498d8333dad5d00c2d6/b8c97b87... HTTP 302
https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaft... Page URL

Detected technologies

WordPress (CMS) Expand

Overall confidence: 100%
Detected patterns

headers link /rel="https:\/\/api\.w\.org\/"/i

PHP (Programming Languages) Expand

Overall confidence: 100%
Detected patterns

headers link /rel="https:\/\/api\.w\.org\/"/i

MySQL (Databases) Expand

Overall confidence: 100%
Detected patterns

headers link /rel="https:\/\/api\.w\.org\/"/i

Nginx (Web Servers) Expand

Overall confidence: 100%
Detected patterns

headers server /nginx(?:\/([\d.]+))?/i

Crazy Egg (Analytics) Expand

Overall confidence: 100%
Detected patterns

script /script\.crazyegg\.com\/pages\/scripts\/\d+\/\d+\.js/i

Facebook (Widgets) Expand

Overall confidence: 100%
Detected patterns

script /\/\/connect\.facebook\.net\/[^\/]*\/[a-z]*\.js/i

Google Analytics (Analytics) Expand

Overall confidence: 100%
Detected patterns

script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Google Tag Manager (Tag Managers) Expand

Overall confidence: 100%
Detected patterns

html /googletagmanager\.com\/ns\.html[^>]+><\/iframe>/i
html //i

Page Statistics

211
Requests

95 %
HTTPS

64 %
IPv6

29
Domains

40
Subdomains

31
IPs

6
Countries

6789 kB
Transfer

8931 kB
Size

0
Cookies

34 Outgoing links

These are links going to different origins than the main page.

URL: https://subscribe.haymarketmedia.com/sub/?p=MPR&f=paid49&s=navbar
Title: Subscribe

Search URL Search Domain Scan URL

URL: https://www.facebook.com/Monthly-Prescribing-Reference-116922999739/

Search URL Search Domain Scan URL

URL: https://twitter.com/empr

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/company/mpr---monthly-prescribing-reference

Search URL Search Domain Scan URL

URL: http://productdirectory.empr.com/
Title: Medical Devices & Products

Search URL Search Domain Scan URL

URL: https://jobs.empr.com/
Title: Jobs

Search URL Search Domain Scan URL

URL: http://www.facebook.com/sharer.php?u=https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/
Title: Share on Facebook

Search URL Search Domain Scan URL

URL: https://twitter.com/share?url=https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/&text=FDA%20to%20Review%20Elexacaftor,%20Tezacaftor,%20Ivacaftor%20Combo%20for%20Cystic%20Fibrosis
Title: Share on Twitter

Search URL Search Domain Scan URL

URL: http://www.linkedin.com/shareArticle?mini=true&url=https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/
Title: Share on LinkedIn

Search URL Search Domain Scan URL

URL: http://reddit.com/submit?url=https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/&title=FDA%20to%20Review%20Elexacaftor,%20Tezacaftor,%20Ivacaftor%20Combo%20for%20Cystic%20Fibrosis
Title: Share on Reddit

Search URL Search Domain Scan URL

URL: https://www.vrtx.com/research-development/pipeline
Title: vrtx.com

Search URL Search Domain Scan URL

URL: https://subscribe.haymarketmedia.com/sub/?p=MPR&f=disc139&s=300X105

Search URL Search Domain Scan URL

URL: https://subscribe.haymarketmedia.com/sub/?p=MPR&f=paid49&s=footer
Title: Subscribe

Search URL Search Domain Scan URL

URL: https://www.cancertherapyadvisor.com/
Title: Cancer Therapy Advisor

Search URL Search Domain Scan URL

URL: https://www.clinicaladvisor.com/
Title: Clinical Advisor

Search URL Search Domain Scan URL

URL: https://www.clinicalpainadvisor.com/
Title: Clinical Pain Advisor

Search URL Search Domain Scan URL

URL: https://www.dermatologyadvisor.com/
Title: Dermatology Advisor

Search URL Search Domain Scan URL

URL: https://www.endocrinologyadvisor.com/
Title: Endocrinology Advisor

Search URL Search Domain Scan URL

URL: https://www.gastroenterologyadvisor.com/
Title: Gastroenterology Advisor

Search URL Search Domain Scan URL

URL: https://www.hematologyadvisor.com/
Title: Hematology Advisor

Search URL Search Domain Scan URL

URL: https://www.infectiousdiseaseadvisor.com/
Title: Infectious Disease Advisor

Search URL Search Domain Scan URL

URL: https://www.mcknights.com/
Title: McKnight's Long Term Care News

Search URL Search Domain Scan URL

URL: https://www.mcknightsseniorliving.com/
Title: McKnight's Senior Living

Search URL Search Domain Scan URL

URL: https://www.medicalbag.com/
Title: Medical Bag

Search URL Search Domain Scan URL

URL: https://www.mycme.com/
Title: myCME

Search URL Search Domain Scan URL

URL: https://www.neurologyadvisor.com/
Title: Neurology Advisor

Search URL Search Domain Scan URL

URL: https://www.oncologynurseadvisor.com/
Title: Oncology Nurse Advisor

Search URL Search Domain Scan URL

URL: https://www.psychiatryadvisor.com/
Title: Psychiatry Advisor

Search URL Search Domain Scan URL

URL: https://www.pulmonologyadvisor.com/
Title: Pulmonology Advisor

Search URL Search Domain Scan URL

URL: https://www.renalandurologynews.com/
Title: Renal & Urology News

Search URL Search Domain Scan URL

URL: https://www.rheumatologyadvisor.com/
Title: Rheumatology Advisor

Search URL Search Domain Scan URL

URL: https://www.thecardiologyadvisor.com/
Title: The Cardiology Advisor

Search URL Search Domain Scan URL

URL: https://haymarketmediaus.com/haymarket-media-medical-privacy-policy/
Title: Privacy Policy

Search URL Search Domain Scan URL

URL: https://haymarketmediaus.com/haymarket-media-inc-us-terms-conditions/
Title: Terms & Conditions

Search URL Search Domain Scan URL

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

http://link.email.empr.com/a/1323/click/65947/2303653/542902fc477add73eb37b498d8333dad5d00c2d6/b8c97b8721167c001d1643c6fe14ac6c9ed5cab8&amp HTTP 302
https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 39

https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1566793872590&ns_c=UTF-8&c8=FDA%20to%20Review%20Elexacaftor%2C%20Tezacaftor%2C%20Ivacaftor%20Combo%20for%20Cystic%20Fibrosis%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&c9= HTTP 302
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1566793872590&ns_c=UTF-8&c8=FDA%20to%20Review%20Elexacaftor%2C%20Tezacaftor%2C%20Ivacaftor%20Combo%20for%20Cystic%20Fibrosis%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&c9=

Request Chain 63

https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1307723831&t=pageview&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&ul=en-us&de=UTF-8&dt=FDA%20to%20Review%20Elexacaftor%2C%20Tezacaftor%2C%20Ivacaftor%20Combo%20for%20Cystic%20Fibrosis%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&_u=aGDAAAAjQ~&jid=428510610&gjid=836061622&cid=1983512316.1566793876&tid=UA-1290429-2&_gid=667140149.1566793876&_r=1&gtm=2wg8e15XFK9V6&cd1=122588%3A0&cd2=cystic%20fibrosis%2Cinborn%20errors%20of%20metabolism%2Cmetabolic%20disorders%2Crespiratory%20diseases%2Fdisorders&cd3=&cd4=&cd5=post&cd6=&cd7=home&cd8=news&cd9=drugs%20in%20the%20pipeline&cd10=fda%20to%20review%20elexacaftor%2C%20tezacaftor%2C%20ivacaftor%20combo%20for%20cystic%20fibrosis&cd11=omn&cd12=13&cd14=false&cd15=&cd16=false&cd17=&cd18=0&cd19=&cd31=&cd32=&cd33=&cd34=Steve%20Duffy&cd35=MPR%20Drug%20News&cd36=&cd37=undefined&cd38=undefined&cd39=undefined&cd40=&cd41=&cd42=&cd43=&cd46=&cd48=&cd50=&cd52=&cd53=home&cd54=&cd55=&cd56=9&cd57=&cd58=&cd62=false&cd63=2019-08-22&cd64=202&cd67=&cd68=undef&cd71=false&cd78=false&cd79=false&cd80=false&cd93=drugs%20in%20the%20pipeline&z=1324242178 HTTP 302
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1983512316.1566793876&jid=428510610&_gid=667140149.1566793876&gjid=836061622&_v=j79&z=1324242178 HTTP 302
https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1983512316.1566793876&jid=428510610&_v=j79&z=1324242178 HTTP 302
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1983512316.1566793876&jid=428510610&_v=j79&z=1324242178&slf_rd=1&random=2014730547

Request Chain 206

https://api-54-218-116-18.b2c.com/api/x?FHwzu1TA4iqLeKle$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 HTTP 302
https://api-54-218-116-18.b2c.com:444/api/4?FHwzu1TA4iqLeKle

Request Chain 207

https://api-34-210-86-189.b2c.com/api/x?X2DDXQsU7BzW334P$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 HTTP 302
https://api-34-210-86-189.b2c.com:444/api/4?X2DDXQsU7BzW334P

Request Chain 208

https://api-54-218-116-18.b2c.com/api/x?dfaPWmTvOg140xr8$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 HTTP 302
https://api-54-218-116-18.b2c.com:444/api/4?dfaPWmTvOg140xr8

Request Chain 215

https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1307723831&t=event&ni=0&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&ul=en-us&de=UTF-8&dt=FDA%20to%20Review%20Elexacaftor%2C%20Tezacaftor%2C%20Ivacaftor%20Combo%20for%20Cystic%20Fibrosis%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=User%20Engagement&ea=Beacon&_u=aGjAAAAjQ~&jid=1153770094&gjid=554820119&cid=1510935939.1566793877&tid=UA-1290429-2&_gid=1626426807.1566793888&_r=1&gtm=2wg8e15XFK9V6&z=284972382 HTTP 302
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1510935939.1566793877&jid=1153770094&_gid=1626426807.1566793888&gjid=554820119&_v=j79&z=284972382 HTTP 302
https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1510935939.1566793877&jid=1153770094&_v=j79&z=284972382 HTTP 302
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1510935939.1566793877&jid=1153770094&_v=j79&z=284972382&slf_rd=1&random=3646715837

Request Chain 216

https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1307723831&t=event&ni=0&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&ul=en-us&de=UTF-8&dt=FDA%20to%20Review%20Elexacaftor%2C%20Tezacaftor%2C%20Ivacaftor%20Combo%20for%20Cystic%20Fibrosis%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=User%20Engagement&ea=Beacon&_u=aGjAAAAjQ~&jid=908817938&gjid=1340627042&cid=1510935939.1566793877&tid=UA-1290429-2&_gid=1185070622.1566793903&_r=1&gtm=2wg8e15XFK9V6&z=1083985752 HTTP 302
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1510935939.1566793877&jid=908817938&_gid=1185070622.1566793903&gjid=1340627042&_v=j79&z=1083985752 HTTP 302
https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1510935939.1566793877&jid=908817938&_v=j79&z=1083985752 HTTP 302
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1510935939.1566793877&jid=908817938&_v=j79&z=1083985752&slf_rd=1&random=2767011988

211 HTTP transactions
7 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2

200

Primary Request / Show response
www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/
Redirect Chain

http://link.email.empr.com/a/1323/click/65947/2303653/542902fc477add73eb37b498d8333dad5d00c2d6/b8c97b8721167c001d1643c6fe14ac6c9ed5cab8&amp
https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-...

100 KB
22 KB

424ms
198ms

Document
text/html

3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 73cbac45cb76e2a376e99469ace61593503a4659d8468221c5b0da3b8ffd06d6

Request headers

:method: GET
:authority: www.empr.com
:scheme: https
:path: /home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: none
accept-encoding: gzip, deflate, br
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status: 200
server: nginx
date: Mon, 26 Aug 2019 04:31:12 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding Accept-Encoding Accept-Encoding,Cookie,X-WPENGINE-SEGMENT
x-distributor: yes
x-pingback: https://www.empr.com/xmlrpc.php
link: <https://www.empr.com/wp-json/>; rel="https://api.w.org/" <https://www.empr.com/?p=122588>; rel=shortlink
wpe-backend: apache
x-cacheable: SHORT
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-pass-why
x-cache-group: normal
x-wpengine-segment: NONHT
content-encoding: gzip

Redirect headers

Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
Status: 302 Found
Cache-Control: no-cache
X-XSS-Protection: 1; mode=block
X-Request-Id: 4ee08277-49e7-42d7-b976-6d7d79242c12
Location: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
X-Runtime: 0.027849
X-Frame-Options: SAMEORIGIN
X-Content-Type-Options: nosniff
Date: Mon, 26 Aug 2019 04:31:11 GMT
Set-Cookie: _session_id=48f66847d155f00a57cdb13940f24d99; path=/; expires=Mon, 26 Aug 2019 16:31:11 -0000; HttpOnly
X-Powered-By: Phusion Passenger 5.3.4
Server: nginx/1.14.0 + Phusion Passenger 5.3.4

GET
H2 200 style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/ 29 KB
5 KB 38ms
24ms Stylesheet
text/css 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/style.min.css?ver=5.2.2
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 4b8fe5c3d0e5ef7a6582185cbf5c535b5d369c8df1da98c03ed69833e55f474d

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Mon, 22 Apr 2019 12:40:04 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5cbdb624-726f"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: text/css
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 shared-style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/ 48 KB
7 KB 38ms
25ms Stylesheet
text/css 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/shared-style.min.css?ver=1553589230
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 33fe4fe8214760f15a5fdd753b5c396ee5b916e5d6f66f79d4765ed260706723

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Tue, 26 Mar 2019 08:33:50 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5c99e3ee-c05a"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: text/css
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/ 239 KB
32 KB 36ms
23ms Stylesheet
text/css 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1564580337
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 7c98b3e37bc9c2a726c320f5db6e1e5a23c2c44d1a5aa35c6fb5e9ae78e64c86

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Wed, 31 Jul 2019 13:38:57 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5d4199f1-3bcc2"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: text/css
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 css
fonts.googleapis.com/ 8 KB
814 B 18ms
16ms Stylesheet
text/css 2a00:1450:4001:81f::200a
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i

Requested by

Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

ESF /

Resource Hash

bb4c48e63332f312f4d1945747e9e319247d26592eec54e38fe75eff833eb130

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=31536000
content-encoding: br
last-modified: Mon, 26 Aug 2019 04:31:12 GMT
server: ESF
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
status: 200
date: Mon, 26 Aug 2019 04:31:12 GMT
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:12 GMT

GET
H2 200 lytics.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/ 37 KB
3 KB 31ms
18ms Stylesheet
text/css 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/lytics.min.css?ver=1561986242
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: ece5f25bbc643556099a200aa2df5c428d74048e55db71c1880afd1adcb425a9

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Mon, 01 Jul 2019 13:04:02 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5d1a04c2-95f6"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: text/css
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 css
fonts.googleapis.com/ 825 B
455 B 17ms
16ms Stylesheet
text/css 2a00:1450:4001:81f::200a
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Bree+Serif&ver=0.1.1

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

ESF /

Resource Hash

19aa6c614f72f6bb67cb17a6169ca551686c2bab5475293c95880f5f32cd830e

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=31536000
content-encoding: br
last-modified: Mon, 26 Aug 2019 04:31:12 GMT
server: ESF
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
status: 200
date: Mon, 26 Aug 2019 04:31:12 GMT
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:12 GMT

GET
H2 200 autosuggest.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/css/ 766 B
580 B 37ms
24ms Stylesheet
text/css 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/css/autosuggest.min.css?ver=3.0.3
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 8689484e31c0c85e3e074f0b59348974f5de4b2eec412e388e2ea32924a41478

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Wed, 10 Jul 2019 08:59:26 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5d25a8ee-2fe"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: text/css
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 jquery.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/ 95 KB
34 KB 51ms
39ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 1db21d816296e6939ba1f42962496e4134ae2b0081e26970864c40c6d02bb1df

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Fri, 17 May 2019 17:08:53 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5cdeeaa5-17a69"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 jquery-migrate.min.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/ 10 KB
4 KB 40ms
27ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 48eb8b500ae6a38617b5738d2b3faec481922a7782246e31d2755c034a45cd5d

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Fri, 20 May 2016 06:11:28 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"573eaa90-2748"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 cookie.min.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/ 2 KB
1 KB 41ms
28ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/cookie.min.js?ver=1.2
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: e828282e92509efc0f7bc57888382c5816bd403e0abbb685eda5c4372cc7daa5

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Tue, 26 Mar 2019 08:33:50 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5c99e3ee-834"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 cc.js Show response
tags.crwdcntrl.net/c/14413/ 38 KB
11 KB 19ms
18ms Script
application/javascript 93.184.220.113
MCI Communication...

General

Check archive.org

Show headers Download Go to

Full URL: https://tags.crwdcntrl.net/c/14413/cc.js?ver=1.4&ns=_cc14413
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 93.184.220.113 London, United Kingdom, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software: ECS (ams/498D) /
Resource Hash: 3c0c418574419249b3fff12c4cdb9a2ad6ddc191fa025ea56d4027552487e78c

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Tue, 13 Aug 2019 19:05:38 GMT
server: ECS (ams/498D)
etag: "5d530a02-98ef+gzip"
vary: Accept-Encoding
x-cache: HIT
content-type: application/javascript
status: 200
cache-control: max-age=86400
content-length: 11304
expires: Tue, 27 Aug 2019 04:31:12 GMT

GET
H2 200 digest.min.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/ 16 KB
5 KB 39ms
27ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/digest.min.js?ver=2.0
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: b3c617e4ee00489d6fb85a53bd88cb1e1f5e71ae5244c54a7fea6b6e7d9921ad

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Wed, 22 May 2019 09:37:40 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5ce51864-3fc1"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 UtilityMove-custom.min.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/ 2 KB
1 KB 46ms
34ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: cffef365e4b53f1a6e9d33a7d42c0d1542b573360f774069589240f75f0e84f1

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Tue, 26 Mar 2019 08:33:50 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5c99e3ee-751"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 polyfill.min.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/ 102 KB
35 KB 54ms
42ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/polyfill.min.js?ver=1553589230
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 59173f786dd1f3802f7ab26fd339aac4099dc10c6cb54a6a92213e6af277592a

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Tue, 26 Mar 2019 08:33:50 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5c99e3ee-19873"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 gpt.js Show response
www.googletagservices.com/tag/js/ 35 KB
12 KB 13ms
13ms Script
text/javascript 2a00:1450:4001:818::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/tag/js/gpt.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

58649dc87a82c3fe3de185bc3e5da95f8f9357899abfc780e2bd14b2988e0c05

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "260 / 520 of 1000 / last-modified: 1566588880"
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, max-age=900, stale-while-revalidate=3600
timing-allow-origin: *
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length: 12352
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:12 GMT

GET
H/1.1 200
OK adtracking.js Show response
s3.amazonaws.com/haymarket-adtracking-js/prod/ 19 KB
19 KB 3710ms
121ms Script
application/javascript 52.216.206.253
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.206.253 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1.amazonaws.com
Software: AmazonS3 /
Resource Hash: 822847109c3aaf484affe599900514bcf4167ceda17fcca7a97b691d780dae25

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Mon, 26 Aug 2019 04:31:17 GMT
Last-Modified: Tue, 15 Jan 2019 22:54:19 GMT
Server: AmazonS3
x-amz-request-id: 828835C895D56214
ETag: "dc289fc811d6d3a62b068bfcda1f8f30"
Content-Type: application/javascript
x-amz-version-id: MlU6AsBGwcOjZYgQIgNYntESpQyo9BbN
Accept-Ranges: bytes
Content-Length: 19158
x-amz-id-2: COvxWft0GGH2S9LG6eH6pqE6cPc3iqAoBfmlM3kyE9NxEm3W2OkBskM2vO6Hna19tpx9LdjjFtI=

GET
H2 200 head.min.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/ 43 KB
13 KB 37ms
25ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/head.min.js?ver=1565874213
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 0891c01a43615c445e85a7d17eab463dfc3de87d3d1e6f023a996cc1680fe586

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Thu, 15 Aug 2019 13:03:33 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5d555825-ac53"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 MPR-logo_website.png
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/ 16 KB
16 KB 19ms
18ms Image
image/png 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/MPR-logo_website.png
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 9c9401c3de840fa118289641c41b6125ca5825612d110a20584d2ba32036a1cf

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
etag: "452a9f099947d43a38734d72a92e9193"
last-modified: Wed, 20 Mar 2019 21:55:07 GMT
server: NetDNA-cache/2.2
x-amz-server-side-encryption: AES256
x-cache: HIT
content-type: image/png
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 16492
expires: Fri, 20 Sep 2019 11:57:16 GMT

GET
H2 200 gtm.js Show response
www.googletagmanager.com/ 135 KB
34 KB 16ms
15ms Script
application/javascript 2a00:1450:4001:81a::2008
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81a::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

c20bb9511b5e428f8815ee2d9473a0a9c1eb96cad17caa13b3b2a292660623d0

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: br
last-modified: Mon, 26 Aug 2019 03:00:00 GMT
server: Google Tag Manager
access-control-allow-headers: Cache-Control
status: 200
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: http://www.googletagmanager.com
cache-control: private, max-age=900
access-control-allow-credentials: true
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 34345
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:12 GMT

GET
H2 200 Avatar-stephen-duffy-96x96.jpg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/08/ 6 KB
6 KB 1284ms
1283ms Image
image/jpeg 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/08/Avatar-stephen-duffy-96x96.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: c9247183a2c474f6571ff97e7e6b8cc5c9219ca45973c6dbbb9d9dcbc50605f2

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:13 GMT
etag: "c3a27c07a9ec4bb8b8b9ecd9473b3458"
last-modified: Mon, 19 Aug 2019 07:11:19 GMT
server: NetDNA-cache/2.2
x-amz-server-side-encryption: AES256
x-cache: MISS
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 5919
expires: Wed, 25 Sep 2019 04:31:13 GMT

GET
H2 200 cysticfibrosiswordcloudss_1279773.jpg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/ 32 KB
32 KB 2333ms
2333ms Image
image/jpeg 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/cysticfibrosiswordcloudss_1279773.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 6454824b40507a03604db2ce37c11b5dc1474e65df280f40910e43c2f4536858

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:14 GMT
etag: "69af2a6bf043e47c07951983dd10f68b"
last-modified: Wed, 20 Mar 2019 09:16:54 GMT
server: NetDNA-cache/2.2
x-amz-server-side-encryption: AES256
x-cache: MISS
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 32818
expires: Wed, 25 Sep 2019 04:31:14 GMT

GET
H2 200 300x100mprsub-300x105.gif
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/01/ 13 KB
14 KB 17ms
17ms Image
image/gif 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/01/300x100mprsub-300x105.gif
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: f0341fe392815f4fedec6d94398334b176ce2fb0eafebc391a82afcb3cc5fef0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:13 GMT
etag: "fb86d90a5bcf340b8bd64802ec39a7a5"
last-modified: Wed, 20 Mar 2019 09:05:43 GMT
server: NetDNA-cache/2.2
x-amz-server-side-encryption: AES256
x-cache: HIT
content-type: image/gif
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 13667
expires: Fri, 20 Sep 2019 12:38:00 GMT

GET
H2 200 spinner.svg
www.empr.com/wp-content/themes/haymarket/assets/svg/src/ 694 B
630 B 99ms
99ms Image
image/svg+xml 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/themes/haymarket/assets/svg/src/spinner.svg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: abb1dd7905b3797711e15609800d43cabead4c0358dc0030a1932a20e82a37d7

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:13 GMT
content-encoding: gzip
last-modified: Tue, 26 Mar 2019 08:33:50 GMT
server: nginx
status: 200
etag: W/"5c99e3ee-2b6"
vary: Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type: image/svg+xml
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js Show response
content.maropost.com/uploads/1323/websites/5/ 3 KB
3 KB 6ms
6ms Script
text/plain 2600:9000:2057:5c00:1b:fadc:b780:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://content.maropost.com/uploads/1323/websites/5/96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js?ver=1.1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:2057:5c00:1b:fadc:b780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: AmazonS3 /
Resource Hash: 3b8eec5229515f9e95a68b635aba1d27d7d91f2e1b726302c53124fe18cefd20

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Sun, 25 Aug 2019 09:04:41 GMT
via: 1.1 7fcb41b117930690c299be9cec4a977a.cloudfront.net (CloudFront)
last-modified: Thu, 27 Sep 2018 21:48:02 GMT
server: AmazonS3
age: 69993
etag: "ff4375eccda3ca6bc54ed96c5d77d9bb"
x-cache: Hit from cloudfront
status: 200
x-amz-cf-pop: FRA6-C1
accept-ranges: bytes
content-length: 2622
x-amz-cf-id: BW1pnZYIM_rU8z_ZA7CMdyC6gfgkJ_afY2XTQzF9VdFI8BghGAYH8w==

GET
H2 200 blocks.min.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/ 7 KB
3 KB 19ms
18ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/blocks.min.js?ver=1565874213
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 2b2f53c9542f12eef99cceef17c6dad6692fe6d3630b9a22d0f6c4bba7b55002

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Thu, 15 Aug 2019 13:03:33 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5d555825-1b42"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 local-storage-lib.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/ 1 KB
917 B 17ms
17ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/local-storage-lib.js?ver=2.0
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 693d39f8b27d78f2a570672b862512cb8e3dee72e8f641cf95ada2d81bac720b

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:13 GMT
content-encoding: gzip
last-modified: Wed, 17 Jul 2019 13:03:16 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5d2f1c94-591"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 npi-manager.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/ 3 KB
1 KB 17ms
17ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/npi-manager.js?ver=2.0
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: ec4b201b52347534c07364e77ab720820b26bca36ffa7376cedfba0c25a3b796

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:13 GMT
content-encoding: gzip
last-modified: Wed, 17 Jul 2019 13:03:16 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5d2f1c94-afc"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H/1.1 200
OK hmi-registration-ui.manifest.js Show response
s3.amazonaws.com/haymarket-reg-js/develop/production/ 799 B
1 KB 2358ms
119ms Script
application/javascript 52.216.206.253
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.manifest.js?ver=0.1.1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.206.253 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1.amazonaws.com
Software: AmazonS3 /
Resource Hash: 4d3e9dbf75d761b4fc344b3be601971eb517ce533c7ce46e093539e03349616e

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Mon, 26 Aug 2019 04:31:17 GMT
Last-Modified: Thu, 01 Aug 2019 16:14:19 GMT
Server: AmazonS3
x-amz-request-id: A39BCB4B2FD17D60
ETag: "6878a8fbe72bde4a3f8ecf5b16523972"
Content-Type: application/javascript
x-amz-version-id: z4vE4G3HGR4cu6UpbJUCgMOgPPNEViV0
Accept-Ranges: bytes
Content-Length: 799
x-amz-id-2: Q3QroN4Q36G+YWj3dh3lFwLhCUPY3QhFJ19+YBKhPzqZpuZUNLRPAp1wRGY6yI0iFZ/0IyI6zeI=

GET
H/1.1 200
OK hmi-registration-ui.vendor.js Show response
s3.amazonaws.com/haymarket-reg-js/develop/production/ 356 KB
356 KB 1563ms
113ms Script
application/javascript 52.216.206.253
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.206.253 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1.amazonaws.com
Software: AmazonS3 /
Resource Hash: 6f6380177618c6862586a5621d5b0e07217ab0ccdacd0a2a1a53b86f21b9ed5d

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Mon, 26 Aug 2019 04:31:17 GMT
Last-Modified: Thu, 01 Aug 2019 16:14:19 GMT
Server: AmazonS3
x-amz-request-id: 1E5BF463CAD517A3
ETag: "f011bd848f5dd264858501030276d904"
Content-Type: application/javascript
x-amz-version-id: 6ZmdlJsSh9vkAhXcUCtt_BjoAU.kCB7l
Accept-Ranges: bytes
Content-Length: 364336
x-amz-id-2: YkuvtgSU2c6WK6wfJdJojaPujWgdFEg/13I1uyrbeeI6sfxM006FnANq/oE6XBqbRRaDZaU/2mk=

GET
H/1.1 200
OK hmi-registration-ui.bundle.js Show response
s3.amazonaws.com/haymarket-reg-js/develop/production/ 1 MB
1 MB 659ms
113ms Script
application/javascript 52.216.206.253
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 52.216.206.253 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: s3-1.amazonaws.com
Software: AmazonS3 /
Resource Hash: e3741cb5d52b90eaf48d32a7e5413650b4cb1a47aeff1f149e5f99cd59a09ea2

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Mon, 26 Aug 2019 04:31:17 GMT
Last-Modified: Thu, 01 Aug 2019 16:14:19 GMT
Server: AmazonS3
x-amz-request-id: A0EFCAA81BAD1A01
ETag: "6f0a7385fc124b239184087c1a7638d5"
Content-Type: application/javascript
x-amz-version-id: wCa6VPmHJ93WvGHO4M908GRyHC2vuvjV
Accept-Ranges: bytes
Content-Length: 1272648
x-amz-id-2: d/lUimww8SZtsk9JH3OxHfOZ/8Y8vX+5xZ84yBg5rymV6qTZTDJVLHX4SCAPYmsnVd4+sxfl6ac=

GET
H2 200 autosuggest.min.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/js/ 4 KB
2 KB 17ms
17ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/js/autosuggest.min.js?ver=3.0.3
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: c93e697d8038c51fe0e5002d6ff046cfe3497e03a47c302684292b3f1eeb6c46

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Wed, 10 Jul 2019 08:59:26 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5d25a8ee-117d"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 frontend.min.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/ 145 KB
39 KB 21ms
21ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 64a0cd363010895321d3015d8c7973aa9ee24623e6ba363e76d1be39b09f4bd5

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Thu, 15 Aug 2019 13:03:33 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5d555825-245d3"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 iab.min.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/ 8 KB
2 KB 18ms
17ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1565874213
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: ae1eff31eff9623af795e27413312563c498759622b7c17ede94ed31b5594e89

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Thu, 15 Aug 2019 13:03:33 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5d555825-1ecd"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 wp-embed.min.js Show response
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/ 1 KB
1003 B 18ms
18ms Script
application/javascript 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/wp-embed.min.js?ver=5.2.2
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 2152557cac69e2bd7d6debef5037a9f554f9209cc305b8141b3329acb10c42b7

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
last-modified: Thu, 30 Aug 2018 12:40:26 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5b87e5ba-57b"
vary: Accept-Encoding, Accept-Encoding
x-cache: HIT
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 integrator.js Show response
adservice.google.de/adsid/ 109 B
171 B 14ms
14ms Script
application/javascript 2a00:1450:4001:818::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://adservice.google.de/adsid/integrator.js?domain=www.empr.com

Requested by

Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin: *
date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
p3p: CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status: 200
cache-control: private, no-cache, no-store
content-disposition: attachment; filename="f.txt"
content-type: application/javascript; charset=UTF-8
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length: 104
x-xss-protection: 0

GET
H2 200 integrator.js Show response
adservice.google.com/adsid/ 109 B
171 B 15ms
14ms Script
application/javascript 2a00:1450:4001:808::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://adservice.google.com/adsid/integrator.js?domain=www.empr.com

Requested by

Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:808::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin: *
date: Mon, 26 Aug 2019 04:31:12 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
p3p: CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status: 200
cache-control: private, no-cache, no-store
content-disposition: attachment; filename="f.txt"
content-type: application/javascript; charset=UTF-8
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length: 104
x-xss-protection: 0

GET
H2 200 pubads_impl_2019081901.js Show response
securepubads.g.doubleclick.net/gpt/ 157 KB
58 KB 42ms
42ms Script
text/javascript 216.58.207.34
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js

Requested by

Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s24-in-f2.1e100.net

Software

sffe /

Resource Hash

d13db8b95f4bea4d1f6acba9dd08e9e026540e8bf28b19133c5e85d42b953b39

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:16 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Mon, 19 Aug 2019 13:05:42 GMT
server: sffe
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, immutable, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 59487
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:16 GMT

GET
H2 200 7341.js Show response
script.crazyegg.com/pages/scripts/0034/ 88 KB
28 KB 20ms
19ms Script
application/x-javascript 2606:4700::6813:9308
Cloudflare

General

Check archive.org

Show headers Download Go to

Full URL: https://script.crazyegg.com/pages/scripts/0034/7341.js?435220
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 9657fb8a0a588adb91904cc27ad6112de087dfc6d0f606e3a0581ab3f11f820d

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:16 GMT
via: 1.1 9a736972b021a4b2382c29923f73ce8b.cloudfront.net (CloudFront)
cf-cache-status: HIT
age: 293
cf-polished: origSize=90069
x-cache: Hit from cloudfront
status: 200
content-encoding: gzip
last-modified: Tue, 20 Aug 2019 14:00:23 GMT
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: application/x-javascript
cache-control: private, max-age=300
x-amz-cf-pop: VIE50-C1
cf-ray: 50c3133eaedccbbc-VIE
x-amz-cf-id: J7QwyhXsonf7d1177jXu8wtqkhS-sLVbVCFHj43GjSOMEZA2Us7R6Q==
cf-bgj: minify

GET
H2 200 analytics.js Show response
www.google-analytics.com/ 43 KB
17 KB 6ms
5ms Script
text/javascript 2a00:1450:4001:81a::200e
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/analytics.js

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81a::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Golfe2 /

Resource Hash

dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a

Security Headers

Name	Value
Strict-Transport-Security	max-age=10886400; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=10886400; includeSubDomains; preload
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Mon, 19 Aug 2019 17:22:41 GMT
server: Golfe2
age: 6460
date: Mon, 26 Aug 2019 02:43:36 GMT
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: public, max-age=7200
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 17803
expires: Mon, 26 Aug 2019 04:43:36 GMT

GET
H/1.1

204
No Content

b2
sb.scorecardresearch.com/
Redirect Chain

https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1566793872590&ns_c=UTF-8&c8=FDA%20to%20Review%20Elexacaftor%2C%20Tezacaftor%2C%20Ivacaftor%20Combo%20for%20Cystic%20Fibrosis%20-%20MPR&c7=h...
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1566793872590&ns_c=UTF-8&c8=FDA%20to%20Review%20Elexacaftor%2C%20Tezacaftor%2C%20Ivacaftor%20Combo%20for%20Cystic%20Fibrosis%20-%20MPR&c7=...

0
248 B

26ms
26ms

Image
text/plain

104.111.214.103
Akamai Technologies

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1566793872590&ns_c=UTF-8&c8=FDA%20to%20Review%20Elexacaftor%2C%20Tezacaftor%2C%20Ivacaftor%20Combo%20for%20Cystic%20Fibrosis%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&c9=
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 104.111.214.103 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS: a104-111-214-103.deploy.static.akamaitechnologies.com
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma: no-cache
Date: Mon, 26 Aug 2019 04:31:16 GMT
Cache-Control: private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection: keep-alive
Content-Length: 0
Expires: Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location: https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1566793872590&ns_c=UTF-8&c8=FDA%20to%20Review%20Elexacaftor%2C%20Tezacaftor%2C%20Ivacaftor%20Combo%20for%20Cystic%20Fibrosis%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&c9=
Pragma: no-cache
Date: Mon, 26 Aug 2019 04:31:16 GMT
Cache-Control: private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection: keep-alive
Content-Length: 0
Expires: Mon, 01 Jan 1990 00:00:00 GMT

GET
H2 200 src.svg
www.empr.com/wp-content/themes/haymarket/assets/svg/ 33 KB
10 KB 102ms
101ms Other
image/svg+xml 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://www.empr.com/wp-content/themes/haymarket/assets/svg/src.svg?ver=1553589230
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 866e74600600f8647c979414828f3538d646101dc8504de84c2ed00e30460811

Request headers

Sec-Fetch-Mode: same-origin
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:16 GMT
content-encoding: gzip
last-modified: Tue, 26 Mar 2019 08:33:50 GMT
server: nginx
status: 200
etag: W/"5c99e3ee-8317"
vary: Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type: image/svg+xml
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 S6uyw4BMUTPHjx4wXiWtFCc.woff2
fonts.gstatic.com/s/lato/v16/ 14 KB
14 KB 5ms
5ms Font
font/woff2 2a00:1450:4001:816::2003
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/lato/v16/S6uyw4BMUTPHjx4wXiWtFCc.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:816::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

036d841b132c14046e26d8f2da1bc634c6ad34885ed1295660694a91c98933a6

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: cors
Referer: https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin: https://www.empr.com
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 23 Aug 2019 19:26:23 GMT
x-content-type-options: nosniff
last-modified: Tue, 23 Jul 2019 03:45:55 GMT
server: sffe
age: 205493
status: 200
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 14044
x-xss-protection: 0
expires: Sat, 22 Aug 2020 19:26:23 GMT

GET
H2 200 chevron-right-white.svg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/ 190 B
399 B 18ms
17ms Image
image/svg+xml 94.31.29.64
Highwinds Network...

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/chevron-right-white.svg
Requested by: Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS: 94.31.29.64.IPYX-077437-ZYO.above.net
Software: NetDNA-cache/2.2 /
Resource Hash: 8e0da2e2d764c1a202d33dd39287784df8ac6bc20c7401ea14f2d62001292856

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1564580337
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:16 GMT
content-encoding: gzip
last-modified: Tue, 26 Mar 2019 08:33:50 GMT
server: NetDNA-cache/2.2
status: 200
etag: W/"5c99e3ee-be"
vary: Accept-Encoding
x-cache: HIT
content-type: image/svg+xml
access-control-allow-origin: *
cache-control: public, max-age=2592000

GET
H2 200 BngRUXZYTXPIvIBgJJSb6u92w7CGwR2oefDo.woff2
fonts.gstatic.com/s/robotoslab/v9/ 11 KB
11 KB 6ms
5ms Font
font/woff2 2a00:1450:4001:816::2003
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/robotoslab/v9/BngRUXZYTXPIvIBgJJSb6u92w7CGwR2oefDo.woff2

Requested by

Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:816::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

4901c9453014d8e210b2f62189f68c2d7964543517e1fc8447924de7d542058a

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: cors
Referer: https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin: https://www.empr.com
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 23 Aug 2019 19:11:42 GMT
x-content-type-options: nosniff
last-modified: Mon, 22 Jul 2019 19:27:03 GMT
server: sffe
age: 206374
status: 200
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 11388
x-xss-protection: 0
expires: Sat, 22 Aug 2020 19:11:42 GMT

GET
H2 200 BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2
fonts.gstatic.com/s/robotoslab/v9/ 11 KB
11 KB 5ms
5ms Font
font/woff2 2a00:1450:4001:816::2003
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/robotoslab/v9/BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:816::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

c68d891f07355e5d0807b4a4f18ac8f16f6e9088277be3134c7efa570022ab2d

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: cors
Referer: https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin: https://www.empr.com
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Thu, 22 Aug 2019 11:21:11 GMT
x-content-type-options: nosniff
last-modified: Mon, 22 Jul 2019 19:19:23 GMT
server: sffe
age: 321005
status: 200
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 11272
x-xss-protection: 0
expires: Fri, 21 Aug 2020 11:21:11 GMT

GET
H2 200 S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
fonts.gstatic.com/s/lato/v16/ 14 KB
14 KB 6ms
5ms Font
font/woff2 2a00:1450:4001:816::2003
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/lato/v16/S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:816::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

9baad10e85c5be8d5697086479983b6b477197103bf8f0f11817b1bdfb9a7451

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: cors
Referer: https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin: https://www.empr.com
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Sun, 25 Aug 2019 03:29:35 GMT
x-content-type-options: nosniff
last-modified: Tue, 23 Jul 2019 03:45:54 GMT
server: sffe
age: 90101
status: 200
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 14176
x-xss-protection: 0
expires: Mon, 24 Aug 2020 03:29:35 GMT

GET
H2 200 S6u8w4BMUTPHjxsAXC-qNiXg7Q.woff2
fonts.gstatic.com/s/lato/v16/ 15 KB
15 KB 5ms
5ms Font
font/woff2 2a00:1450:4001:816::2003
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/lato/v16/S6u8w4BMUTPHjxsAXC-qNiXg7Q.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:816::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

fe4bbdad1d6dff75cde79f8afc07f29502bd4708cb0ce5f552083c3d81ba8382

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: cors
Referer: https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin: https://www.empr.com
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Sun, 25 Aug 2019 03:27:53 GMT
x-content-type-options: nosniff
last-modified: Tue, 23 Jul 2019 03:45:51 GMT
server: sffe
age: 90203
status: 200
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 14864
x-xss-protection: 0
expires: Mon, 24 Aug 2020 03:27:53 GMT

GET
H2 200 js Show response
www.google-analytics.com/gtm/ 56 KB
21 KB 25ms
24ms Script
application/javascript 2a00:1450:4001:81a::200e
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/gtm/js?id=GTM-T8P2ZZ9&t=gtm1&cid=1983512316.1566793876

Requested by

Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81a::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

2b0cf0b94f5307f8b64f855263d5de010fb74353be7a433cc5a59561cdfaaa1f

Security Headers

Name	Value
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:16 GMT
content-encoding: br
server: Google Tag Manager
access-control-allow-headers: Cache-Control
status: 200
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: http://www.googletagmanager.com
cache-control: private, max-age=900
access-control-allow-credentials: true
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 21537
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:16 GMT

GET 96ac8580a54c3864c4ba15ff4a38efdcb7084985.js
mpct1.maropost.com/accounts/1323/websites/5/track/ 0
0

GET
H2 200 lio.js Show response
c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/ 45 KB
11 KB 20ms
20ms Script
application/javascript 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to

Full URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Requested by: Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 803e3ba42413340bcc0c185e1b5f40bfcc115ed3a52832ffcdf7827cbf239be0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray: 50c3133f5e7c8c74-VIE
date: Mon, 26 Aug 2019 04:31:16 GMT
via: 1.1 google
cf-cache-status: HIT
server: cloudflare
age: 1581
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: application/javascript
status: 200
cache-control: public, max-age=7200
content-encoding: br
expires: Mon, 26 Aug 2019 06:31:16 GMT

GET
H2 200 most-widget Show response
www.empr.com/wp-json/haymarket/v1/ 4 KB
2 KB 100ms
100ms XHR
application/json 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.empr.com/wp-json/haymarket/v1/most-widget?id=most-5

Requested by

Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-3-225-154-29.compute-1.amazonaws.com

Software

nginx /

Resource Hash

93207da1092d103352d9b4a9234709f727472e17949513f970a7b69b96cb7177

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:16 GMT
content-encoding: gzip
x-content-type-options: nosniff
x-cacheable: SHORT
x-cache: HIT: 2
status: 200
x-wpengine-segment: NONHT
x-cache-group: normal
access-control-allow-headers: Authorization, Content-Type
allow: GET
wpe-backend: apache
server: nginx
vary: Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type: application/json; charset=UTF-8
access-control-expose-headers: X-WP-Total, X-WP-TotalPages
cache-control: max-age=600, must-revalidate
x-distributor: yes
x-robots-tag: noindex
link: <https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why

GET
H2 200 122588 Show response
www.empr.com/wp-json/haymarket/v1/infinite-scroll/ 8 KB
2 KB 100ms
100ms XHR
application/json 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.empr.com/wp-json/haymarket/v1/infinite-scroll/122588

Requested by

Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-3-225-154-29.compute-1.amazonaws.com

Software

nginx /

Resource Hash

7ca1dac50f8e7bff712b571035fb07ca427711e9153130067c7dfe9994bbc814

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:16 GMT
content-encoding: gzip
x-content-type-options: nosniff
x-cacheable: SHORT
x-cache: HIT: 1
status: 200
x-wpengine-segment: NONHT
x-cache-group: normal
access-control-allow-headers: Authorization, Content-Type
allow: GET
wpe-backend: apache
server: nginx
vary: Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type: application/json; charset=UTF-8
access-control-expose-headers: X-WP-Total, X-WP-TotalPages
cache-control: max-age=600, must-revalidate
x-distributor: yes
x-robots-tag: noindex
link: <https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why

GET
H2 200 partial-login Show response
www.empr.com/wp-json/haymarket/v1/ 634 B
854 B 99ms
99ms XHR
application/json 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL

https://www.empr.com/wp-json/haymarket/v1/partial-login?subid=&subemail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1

Requested by

Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),

Reverse DNS

ec2-3-225-154-29.compute-1.amazonaws.com

Software

nginx /

Resource Hash

ad16911f49d3e72d789bfe438841576129e86d69f42bcaddf489d3523ed69951

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:16 GMT
content-encoding: gzip
x-content-type-options: nosniff
x-cacheable: SHORT
x-cache: HIT: 7
status: 200
x-wpengine-segment: NONHT
x-cache-group: normal
access-control-allow-headers: Authorization, Content-Type
allow: GET
wpe-backend: apache
server: nginx
vary: Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type: application/json; charset=UTF-8
access-control-expose-headers: X-WP-Total, X-WP-TotalPages
cache-control: max-age=600, must-revalidate
x-distributor: yes
x-robots-tag: noindex
link: <https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why

GET
H2 200 / Show response
accounts.haymarketmedia.com/sso/check/ 45 B
441 B 104ms
103ms XHR
application/json 35.174.96.0
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://accounts.haymarketmedia.com/sso/check/?gn=101
Requested by: Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 35.174.96.0 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-35-174-96-0.compute-1.amazonaws.com
Software: Microsoft-IIS/8.5 / ASP.NET
Resource Hash: 916b46685de3064525220ba828d946e60ab332f5e65c62d7df5fe9877f9c54b2

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:16 GMT
x-aspnetmvc-version: 4.0
server: Microsoft-IIS/8.5
x-aspnet-version: 4.0.30319
x-powered-by: ASP.NET
status: 200
content-type: application/json; charset=utf-8
access-control-allow-origin: https://www.empr.com
cache-control: private
access-control-allow-credentials: true
content-length: 45

GET beacon.js
www.medtargetsystem.com/javascript/ 0
0

GET
H2 200 linkid.js Show response
www.google-analytics.com/plugins/ua/ 2 KB
922 B 5ms
5ms Script
text/javascript 2a00:1450:4001:81a::200e
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google-analytics.com/plugins/ua/linkid.js

Requested by

Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81a::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 03:59:16 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Thu, 21 Apr 2016 03:17:22 GMT
server: sffe
age: 1920
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: public, max-age=3600
accept-ranges: bytes
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 856
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:59:16 GMT

GET tag.aspx
ml314.com/ 0
0

GET atrk.js
d31qbv1cthcecs.cloudfront.net/ 0
0

GET
H/1.1 200
OK gg.js Show response
sb.scorecardresearch.com/rs/pt/ 2 KB
1 KB 26ms
25ms Script
application/x-javascript 104.111.214.103
Akamai Technologies

General

Check archive.org

Show headers Download Go to

Full URL: https://sb.scorecardresearch.com/rs/pt/gg.js
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 104.111.214.103 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS: a104-111-214-103.deploy.static.akamaitechnologies.com
Software: /
Resource Hash: d0e90581c7b707bcad9f78f9b066371e6b1377d993ff03cbdee7193d6068ac78

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Mon, 26 Aug 2019 04:31:16 GMT
Content-Encoding: gzip
Connection: keep-alive
X-N: S
Content-Length: 1246
Vary: Accept-Encoding
Content-Type: application/x-javascript

GET
H2 200 fbevents.js Show response
connect.facebook.net/en_US/ 88 KB
23 KB 6ms
5ms Script
application/x-javascript 2a03:2880:f01c:8012:face:b00c:0:3
Facebook

General

Check archive.org

Show headers Download Go to

Full URL

https://connect.facebook.net/en_US/fbevents.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),

Reverse DNS

Software

Resource Hash

f15f778cd39043a166a29f654b1191bc6fbf8043a8cc3477c42764b14b919dec

Security Headers

Name	Value
Content-Security-Policy	default-src * data: blob:;script-src .facebook.com .fbcdn.net .facebook.net .google-analytics.com .virtualearth.net .google.com 127.0.0.1:* .spotilocal.com: 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' ;connect-src .facebook.com facebook.com .fbcdn.net .facebook.net .spotilocal.com: wss://.facebook.com: https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security	max-age=31536000; preload; includeSubDomains
X-Content-Type-Options	nosniff
X-Frame-Options	DENY
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=31536000; preload; includeSubDomains
content-encoding: gzip
x-content-type-options: nosniff
status: 200
content-length: 23404
x-xss-protection: 0
pragma: public
x-fb-debug: aV2IjdSP/+sdg/ggK1CCKQm/vz4ujuoGJgeifyykUkVnUQ/O8xwE/K93gsd4o77OVz/khLY5+bMZV/jZUjbvMg==
x-fb-trip-id: 365799557
x-frame-options: DENY
date: Mon, 26 Aug 2019 04:31:16 GMT
vary: Origin, Accept-Encoding
access-control-allow-methods: OPTIONS
content-type: application/x-javascript; charset=utf-8
access-control-allow-origin: https://connect.facebook.net
access-control-expose-headers: X-FB-Debug, X-Loader-Length
cache-control: public, max-age=1200
access-control-allow-credentials: true
content-security-policy: default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires: Sat, 01 Jan 2000 00:00:00 GMT

GET ta
mt.sitomobile.com/sync/ 0
0

GET up_loader.1.1.0.js
js.adsrvr.org/ 0
0

GET
H2 200 io.min.js Show response
c.lytics.io/static/v2/ 13 KB
6 KB 20ms
19ms Script
application/javascript 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to

Full URL: https://c.lytics.io/static/v2/io.min.js
Requested by: Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: b2435070f04e40c2666a729a016c60355b2025c969c3b7857489b7c8b2755bc2

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray: 50c3133fae908c74-VIE
date: Mon, 26 Aug 2019 04:31:16 GMT
via: 1.1 google
cf-cache-status: HIT
last-modified: Wed, 26 Jun 2019 19:48:45 GMT
server: cloudflare
age: 2129
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: application/javascript
status: 200
cache-control: public, max-age=7200
content-encoding: br
expires: Mon, 26 Aug 2019 06:31:16 GMT

GET
H2

200

ga-audiences
www.google.de/ads/
Redirect Chain

https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1307723831&t=pageview&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaft...
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1983512316.1566793876&jid=428510610&_gid=667140149.1566793876&gjid=836061622&_v=j79&z=1324242178
https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1983512316.1566793876&jid=428510610&_v=j79&z=1324242178
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1983512316.1566793876&jid=428510610&_v=j79&z=1324242178&slf_rd=1&random=2014730547

42 B
109 B

17ms
17ms

Image
image/gif

2a00:1450:4001:821::2003
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1983512316.1566793876&jid=428510610&_v=j79&z=1324242178&slf_rd=1&random=2014730547

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:821::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:16 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
cache-control: no-cache, no-store, must-revalidate
content-type: image/gif
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:16 GMT
x-content-type-options: nosniff
server: cafe
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 302
content-type: text/html; charset=UTF-8
location: https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1983512316.1566793876&jid=428510610&_v=j79&z=1324242178&slf_rd=1&random=2014730547
cache-control: no-cache, no-store, must-revalidate
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 0
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 1073716492693685 Show response
connect.facebook.net/signals/config/ 307 KB
78 KB 7ms
7ms Script
application/x-javascript 2a03:2880:f01c:8012:face:b00c:0:3
Facebook

General

Check archive.org

Show headers Download Go to

Full URL

https://connect.facebook.net/signals/config/1073716492693685?v=2.9.4&r=stable

Requested by

Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),

Reverse DNS

Software

Resource Hash

93c4a8cc5d4782ed85c9a7661ce68d1e7e7e6d4a91a57219f649f77564617460

Security Headers

Name	Value
Content-Security-Policy	default-src * data: blob:;script-src .facebook.com .fbcdn.net .facebook.net .google-analytics.com .virtualearth.net .google.com 127.0.0.1:* .spotilocal.com: 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' ;connect-src .facebook.com facebook.com .fbcdn.net .facebook.net .spotilocal.com: wss://.facebook.com: https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security	max-age=31536000; preload; includeSubDomains
X-Content-Type-Options	nosniff
X-Frame-Options	DENY
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=31536000; preload; includeSubDomains
content-encoding: gzip
x-content-type-options: nosniff
status: 200
content-length: 79754
x-xss-protection: 0
pragma: public
x-fb-debug: 5Ha+0JV/qedlOmgLlbRvcCSKRZniAVQFQY8+E4p5frk004LG7xcWGlOEq6yYDmuarTXq7b4/f3njsORdwB81nA==
x-fb-trip-id: 365799557
x-frame-options: DENY
date: Mon, 26 Aug 2019 04:31:16 GMT
vary: Origin, Accept-Encoding
access-control-allow-methods: OPTIONS
content-type: application/x-javascript; charset=utf-8
access-control-allow-origin: https://connect.facebook.net
access-control-expose-headers: X-FB-Debug, X-Loader-Length
cache-control: public, max-age=1200
access-control-allow-credentials: true
content-security-policy: default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires: Sat, 01 Jan 2000 00:00:00 GMT

GET
H2 200 4 Show response
c.lytics.io/cid/ 77 B
331 B 135ms
135ms Script
text/javascript 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to

Full URL: https://c.lytics.io/cid/4?callback=jQuery112406228125480494806_1566793872493&_=1566793872494
Requested by: Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 2812eb6544ecaf48d82268181b585aad6c382f97e7ce775d9b2c7587983d0530

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray: 50c3133fdea88c74-VIE
pragma: no-cache
date: Mon, 26 Aug 2019 04:31:16 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: text/javascript
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
content-encoding: br
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
expires: 0

GET
H2 200 inferredEvents.js Show response
connect.facebook.net/signals/plugins/ 1 KB
1 KB 6ms
5ms Script
application/x-javascript 2a03:2880:f01c:8012:face:b00c:0:3
Facebook

General

Check archive.org

Show headers Download Go to

Full URL

https://connect.facebook.net/signals/plugins/inferredEvents.js?v=2.9.4

Requested by

Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),

Reverse DNS

Software

Resource Hash

cd1c301a8e7960a1786e2a959226b0b78b56dbea284bd114265f1662d6ca280e

Security Headers

Name	Value
Content-Security-Policy	default-src * data: blob:;script-src .facebook.com .fbcdn.net .facebook.net .google-analytics.com .virtualearth.net .google.com 127.0.0.1:* .spotilocal.com: 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' ;connect-src .facebook.com facebook.com .fbcdn.net .facebook.net .spotilocal.com: wss://.facebook.com: https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
Strict-Transport-Security	max-age=31536000; preload; includeSubDomains
X-Content-Type-Options	nosniff
X-Frame-Options	DENY
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=31536000; preload; includeSubDomains
content-encoding: gzip
x-content-type-options: nosniff
status: 200
content-length: 772
x-xss-protection: 0
pragma: public
x-fb-debug: N7kyvnUX3IKgRQ8LqyUOklLTzZfO7BxwxfxGog4s0MDAN721OVnDvOs0CyUMDXuTQLPIkyVeHkF8pk+JHsFcmA==
x-fb-trip-id: 365799557
x-frame-options: DENY
date: Mon, 26 Aug 2019 04:31:16 GMT
vary: Accept-Encoding
content-type: application/x-javascript; charset=utf-8
cache-control: public, max-age=1200
content-security-policy: default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
expires: Sat, 01 Jan 2000 00:00:00 GMT

GET
H2 200 /
www.facebook.com/tr/ 44 B
250 B 6ms
6ms Image
image/gif 2a03:2880:f11c:8083:face:b00c:0:25de
Facebook

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.facebook.com/tr/?id=1073716492693685&ev=PageView&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&rl=&if=false&ts=1566793876513&sw=1600&sh=1200&v=2.9.4&r=stable&ec=0&o=30&fbp=fb.1.1566793876512.2141910111&it=1566793876425&coo=false&rqm=GET

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),

Reverse DNS

Software

proxygen-bolt /

Resource Hash

10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:16 GMT
last-modified: Fri, 21 Dec 2012 00:00:01 GMT
server: proxygen-bolt
strict-transport-security: max-age=31536000; includeSubDomains
content-type: image/gif
status: 200
cache-control: no-cache, must-revalidate, max-age=0
content-length: 44
expires: Mon, 26 Aug 2019 04:31:16 GMT

GET
H2 200 8da70cfbeb5a180f6aa334afaaa4cf63
api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/ Frame FE17 0
0 131ms
131ms Document
text/html 35.227.192.113
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL: https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/8da70cfbeb5a180f6aa334afaaa4cf63?segments=true&mergestate=true&ts=1566793876588
Requested by: Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS: 113.192.227.35.bc.googleusercontent.com
Software: lytics.io da211be9ac4fd39788a5a52ac0531a5ed52e2f9d /
Resource Hash

Request headers

:method: GET
:authority: api.lytics.io
:scheme: https
:path: /api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/8da70cfbeb5a180f6aa334afaaa4cf63?segments=true&mergestate=true&ts=1566793876588
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode: nested-navigate
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: cross-site
referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
accept-encoding: gzip, deflate, br
cookie: __cfduid=ddf8031a6fae32dd119f54dc67590b05a1566793876; seerid=8da70cfbeb5a180f6aa334afaaa4cf63
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode: nested-navigate
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653

Response headers

status: 200
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
access-control-allow-methods: GET
access-control-allow-origin
content-encoding: gzip
content-type: text/html
server: lytics.io da211be9ac4fd39788a5a52ac0531a5ed52e2f9d
date: Mon, 26 Aug 2019 04:31:16 GMT
content-length: 294
via: 1.1 google
alt-svc: clear

POST
H2 200 /
www.facebook.com/tr/ Frame FDC1 0
0 11ms
6ms Document
text/plain 2a03:2880:f11c:8083:face:b00c:0:25de
Facebook

General

Check archive.org

Show headers Download Go to

Full URL

https://www.facebook.com/tr/

Requested by

Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),

Reverse DNS

Software

proxygen-bolt /

Resource Hash

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains

Request headers

:method: POST
:authority: www.facebook.com
:scheme: https
:path: /tr/
content-length: 3728
pragma: no-cache
cache-control: no-cache
origin: https://www.empr.com
upgrade-insecure-requests: 1
content-type: application/x-www-form-urlencoded
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode: nested-navigate
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: cross-site
referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
accept-encoding: gzip, deflate, br
Origin: https://www.empr.com
Upgrade-Insecure-Requests: 1
Content-Type: application/x-www-form-urlencoded
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode: nested-navigate
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653

Response headers

status: 200
content-type: text/plain
access-control-allow-origin: https://www.empr.com
access-control-allow-credentials: true
strict-transport-security: max-age=31536000; includeSubDomains
content-length: 0
server: proxygen-bolt
date: Mon, 26 Aug 2019 04:31:17 GMT

GET
H2 200 pathfora.min.js Show response
c.lytics.io/static/ 98 KB
20 KB 18ms
13ms Script
application/javascript 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to

Full URL: https://c.lytics.io/static/pathfora.min.js
Requested by: Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 4215e6200c04a4874f3d23c78af23fcd22b5bc3bc916237fd95c108aaae38735

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray: 50c313438fb58c74-VIE
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
cf-cache-status: HIT
last-modified: Wed, 03 Jul 2019 23:03:58 GMT
server: cloudflare
age: 1763
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: application/javascript
status: 200
cache-control: public, max-age=7200
content-encoding: br
expires: Mon, 26 Aug 2019 06:31:17 GMT

GET
H2 200 43bffbce6f25564c8e2145a11836ff9f
c.lytics.io/c/ 35 B
106 B 153ms
148ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f?_ts=1566793877012&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_e=pv&utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&_sesstart=1&_tz=2&_ul=en-US&_sz=1600x1200&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c313438fb98c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 43bffbce6f25564c8e2145a11836ff9f
c.lytics.io/c/ 35 B
95 B 153ms
148ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f?publicationId=13&channel=home&pagetype=post&tags=cystic%20fibrosis%2Cinborn%20errors%20of%20metabolism%2Cmetabolic%20disorders%2Crespiratory%20diseases%2Fdisorders&categories=drugs%20in%20the%20pipeline&pagename=FDA%20to%20Review%20Elexacaftor%2C%20Tezacaftor%2C%20Ivacaftor%20Combo%20for%20Cystic%20Fibrosis&author=Steve%20Duffy&section=home%3Anews%3Adrugs%20in%20the%20pipeline%3Afda%20to%20review%20elexacaftor%2C%20tezacaftor%2C%20ivacaftor%20combo%20for%20cystic%20fibrosis&email=nguyentt%40sutterhealth.org&user_id=0&cpn=pcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019&login=nguyentt%40sutterhealth.org&userstate=CA&userspecialty=&userprofession=Physician&_ts=1566793877013&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c313438fba8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
94 B 158ms
158ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1566793872432&event=gtm.js&gtm.uniqueEventId=15&_ts=1566793877013&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31343afc18c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
94 B 160ms
159ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.AdBlocking=&_ts=1566793877013&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c313442fe48c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 148ms
148ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NHTFlag=false&_ts=1566793877014&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c313447ff28c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 152ms
152ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleId=122588%3A0&_ts=1566793877014&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c313447ff38c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 146ms
146ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleType=MPR%20Drug%20News&_ts=1566793877014&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c313449ffa8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 143ms
143ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.MetaData=&_ts=1566793877015&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134518188c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 152ms
152ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Type=post&_ts=1566793877015&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134568248c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 146ms
145ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.ScrollDepth=&_ts=1566793877015&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31345782f8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 148ms
147ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.cmeActivityId=&_ts=1566793877016&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31345883b8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 146ms
145ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PrintSource=&_ts=1566793877016&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134608588c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 139ms
138ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.SEOScore=&_ts=1566793877016&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31346586f8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 141ms
141ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.Prefix=omn&_ts=1566793877016&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134668728c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 140ms
140ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.PublicationId=13&_ts=1566793877017&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31346787f8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 146ms
146ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Author=Steve%20Duffy&_ts=1566793877017&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31346e89c8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 146ms
146ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.PremiumMonograph=&_ts=1566793877018&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134738b28c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 141ms
140ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.Geolocation=&_ts=1566793877019&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134748b48c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 138ms
138ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Activity.Name=&_ts=1566793877019&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134758b58c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 145ms
145ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GenericEvents=&_ts=1566793877019&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31347d8d18c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 142ms
142ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.CurrencyCode=&_ts=1566793877019&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134828df8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 145ms
145ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.OrderId=&_ts=1566793877020&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134828e38c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 143ms
142ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Drug.CompanyName=&_ts=1566793877020&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134838e78c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
124 B 144ms
143ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.IsPremiumMonograph=false&_ts=1566793877020&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31348c90c8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 145ms
144ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GatingType=post%3Anone&_ts=1566793877020&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31349091b8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 142ms
141ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Company=&_ts=1566793877021&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31349191f8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 140ms
139ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Discipline=&_ts=1566793877021&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134919208c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
165 B 143ms
143ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Asset=&_ts=1566793877021&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31349a9428c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
101 B 144ms
144ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PublishDate=2019-08-22&_ts=1566793877021&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31349f95c8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 144ms
144ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Curation=false&_ts=1566793877021&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31349f95f8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 151ms
150ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.WordCount=202&_ts=1566793877022&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c31349f9638c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 144ms
144ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.CreditType=&_ts=1566793877022&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134a89818c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 140ms
140ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.ActivityResult=&_ts=1566793877022&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134ad9998c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 142ms
142ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.NumberofAdCalls=9&_ts=1566793877022&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134ad99a8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 143ms
143ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.ProductsInCart=&_ts=1566793877022&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134ae99d8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 142ms
142ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section1=home&_ts=1566793877023&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134b79d28c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 137ms
136ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section2=home%3Anews&_ts=1566793877023&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134bb9ef8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 142ms
142ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section3=home%3Anews%3Adrugs%20in%20the%20pipeline&_ts=1566793877023&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134bc9f48c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 144ms
141ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section4=home%3Anews%3Adrugs%20in%20the%20pipeline%3Afda%20to%20review%20elexacaftor%2C%20tezacaftor%2C%20ivacaftor%20combo%20for%20cystic%20fibrosis&_ts=1566793877023&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134bda0e8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 141ms
141ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Tags=cystic%20fibrosis%2Cinborn%20errors%20of%20metabolism%2Cmetabolic%20disorders%2Crespiratory%20diseases%2Fdisorders&_ts=1566793877023&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134c5a488c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 143ms
143ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Categories=drugs%20in%20the%20pipeline&_ts=1566793877024&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134c9a598c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 142ms
142ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.LoggedIn=false&_ts=1566793877024&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134caa638c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 147ms
147ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Login=&_ts=1566793877024&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134cba6b8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
231 B 146ms
145ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SocSSN=&_ts=1566793877024&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134d4a968c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 140ms
140ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SSO=3&_ts=1566793877024&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134d7aa28c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 147ms
146ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubscriberId=0&_ts=1566793877025&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134d8aa38c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 143ms
143ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Source=&_ts=1566793877025&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134daaac8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 142ms
141ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Profession=Physician&_ts=1566793877025&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134e2ac68c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 145ms
145ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Specialty=&_ts=1566793877025&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134e5ad68c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 146ms
145ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubProfession=&_ts=1566793877025&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134e7add8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 142ms
141ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubSpecialty=&_ts=1566793877026&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:18 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134e9ae48c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
116 B 148ms
147ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.JobTitle=&_ts=1566793877026&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:19 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134f0af98c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 140ms
140ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CampaignCodes=pcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019&_ts=1566793877026&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:19 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134f4b028c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
94 B 147ms
147ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Country=&_ts=1566793877026&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:19 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134f5b168c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
95 B 139ms
139ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Company=&_ts=1566793877027&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:19 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134f7b1e8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
95 B 164ms
163ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CompanySize=&_ts=1566793877027&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:19 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c3134ffb3c8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
104 B 143ms
143ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsHaymarket=false&_ts=1566793877027&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:19 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c313502b458c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 143ms
142ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsTracked=true&_ts=1566793877027&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:19 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c313504b4d8c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 147ms
146ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsFromAim=false&_ts=1566793877028&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:19 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c313505b538c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 144ms
143ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NpiNumber=1619909975&_ts=1566793877028&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:19 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c313510b828c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

GET
H2 200 default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 35 B
93 B 145ms
144ms Image
image/gif 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1566793876335&event=gtm.js&gtm.uniqueEventId=3&_ts=1566793877028&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&_uid=8da70cfbeb5a180f6aa334afaaa4cf63&_getid=t&_v=2.0.0&_ca=jstag1
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:19 GMT
via: 1.1 google
server: cloudflare
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status: 200
access-control-allow-methods: GET, POST
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
cf-ray: 50c313511b848c74-VIE
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length: 35
expires: 0

POST
H2 200 /
www.facebook.com/tr/ Frame 07A9 0
0 11ms
10ms Document
text/plain 2a03:2880:f11c:8083:face:b00c:0:25de
Facebook

General

Check archive.org

Show headers Download Go to

Full URL

https://www.facebook.com/tr/

Requested by

Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),

Reverse DNS

Software

proxygen-bolt /

Resource Hash

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains

Request headers

:method: POST
:authority: www.facebook.com
:scheme: https
:path: /tr/
content-length: 12973
pragma: no-cache
cache-control: no-cache
origin: https://www.empr.com
upgrade-insecure-requests: 1
content-type: application/x-www-form-urlencoded
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode: nested-navigate
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site: cross-site
referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
accept-encoding: gzip, deflate, br
Origin: https://www.empr.com
Upgrade-Insecure-Requests: 1
Content-Type: application/x-www-form-urlencoded
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode: nested-navigate
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653

Response headers

status: 200
content-type: text/plain
access-control-allow-origin: https://www.empr.com
access-control-allow-credentials: true
strict-transport-security: max-age=31536000; includeSubDomains
content-length: 0
server: proxygen-bolt
date: Mon, 26 Aug 2019 04:31:17 GMT

GET
H2 200 8da70cfbeb5a180f6aa334afaaa4cf63 Show response
api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/ 181 KB
29 KB 320ms
320ms XHR
application/json 35.227.192.113
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL: https://api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/8da70cfbeb5a180f6aa334afaaa4cf63?limit=30&contentsegment=ee9fe9a51cf2f1774e42f33abc9ca99c&shuffle=true
Requested by: Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1565874213
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS: 113.192.227.35.bc.googleusercontent.com
Software: lytics.io da211be9ac4fd39788a5a52ac0531a5ed52e2f9d /
Resource Hash: 7aa2554a48630910b6d533d8491a7ca973738d06eef61c777a5dcaf4930bba63

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:17 GMT
content-encoding: gzip
server: lytics.io da211be9ac4fd39788a5a52ac0531a5ed52e2f9d
access-control-allow-headers: Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
status: 200
access-control-allow-methods: GET
content-type: application/json
access-control-allow-origin: https://www.empr.com
alt-svc: clear
via: 1.1 google

GET
H2 200 pathfora.min.css
c.lytics.io/static/ 20 KB
3 KB 18ms
18ms Stylesheet
text/css 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to

Full URL: https://c.lytics.io/static/pathfora.min.css
Requested by: Host: c.lytics.io
URL: https://c.lytics.io/static/pathfora.min.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 58aa5964d6f5dc68b2180e943ea63b6031c0ba83e44d9815e724b10f2f615f9f

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray: 50c31343afc48c74-VIE
date: Mon, 26 Aug 2019 04:31:17 GMT
via: 1.1 google
cf-cache-status: HIT
last-modified: Wed, 03 Jul 2019 23:03:58 GMT
server: cloudflare
age: 1762
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: text/css; charset=utf-8
status: 200
cache-control: public, max-age=7200
content-encoding: br
expires: Mon, 26 Aug 2019 06:31:17 GMT

GET
H2 200 config.js Show response
c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/ 91 KB
10 KB 20ms
19ms Script
application/javascript 2606:4700:20::6819:5365
Cloudflare

General

Check archive.org

Show headers Download Go to

Full URL: https://c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/config.js
Requested by: Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software: cloudflare /
Resource Hash: 5ff91653d02d048ed74ad7a92e1aa3545b383e23333248405b6d1819f14be72b

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray: 50c313513b8f8c74-VIE
date: Mon, 26 Aug 2019 04:31:19 GMT
via: 1.1 google
cf-cache-status: HIT
server: cloudflare
age: 1583
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
content-type: application/javascript
status: 200
cache-control: public, max-age=7200
content-encoding: br
expires: Mon, 26 Aug 2019 06:31:19 GMT

GET
H2 200 css
fonts.googleapis.com/ 1 KB
477 B 16ms
16ms Stylesheet
text/css 2a00:1450:4001:81f::200a
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.googleapis.com/css?family=Lato:400,900

Requested by

Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

ESF /

Resource Hash

4bd7ab38b940371c161b19f0cf34bdfdeaac480eda86b13c29591ed01ed67c36

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security: max-age=31536000
content-encoding: br
last-modified: Mon, 26 Aug 2019 04:31:17 GMT
server: ESF
link: <https://fonts.gstatic.com>; rel=preconnect; crossorigin
status: 200
date: Mon, 26 Aug 2019 04:31:17 GMT
x-frame-options: SAMEORIGIN
content-type: text/css; charset=utf-8
access-control-allow-origin: *
cache-control: private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:17 GMT

GET
DATA 200
OK truncated
/ 5 KB
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: d9593473fc4d73446eac1a620bb1bbe590fc80d61d8909484dfee64ae522b787

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type: image/png

GET 13
subapi.haymarketmedia.com/newsletter/ 0
0

GET
DATA 200
OK truncated
/ 24 KB
0 Image
image/gif

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 65f72bc49f7e243cf332df6eb265d987e4c6e997e7aecd813ceace591f805071

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type: image/gif

GET
DATA 200
OK truncated
/ 82 KB
0 Image
image/svg+xml

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: ad9d820f1802abd0f80d4e260c43cd6c92d643c926732a00296821182ae3f9c7

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type: image/svg+xml

GET
H2 200 garyleroy_1488034.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 582 KB
583 KB 103ms
102ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/garyleroy_1488034.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 490af8228469ff03104a571672082e6e5ac79e02998f766465dc36712b980818

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:19 GMT
last-modified: Wed, 20 Mar 2019 21:35:38 GMT
server: nginx
etag: "b3ce9c3ad1ff88446cc40fe9463daade"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 596450
expires: Wed, 25 Sep 2019 04:31:19 GMT

GET
H2 200 hospitalroomg536907565_1490839.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 29 KB
29 KB 479ms
478ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/hospitalroomg536907565_1490839.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: a8a0e6b52ee335dc5282680c7a4d6aae56351925539dae786f4b8d32cdabe451

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:19 GMT
last-modified: Thu, 21 Mar 2019 03:46:37 GMT
server: nginx
etag: "ea42ecdc157f48c83d75569d2c4dc77c"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 29654
expires: Wed, 25 Sep 2019 04:31:19 GMT

GET
H2 200 cannabis-edibles-G-1087610076.jpg
www.empr.com/wp-content/uploads/sites/7/2019/08/ 34 KB
34 KB 387ms
386ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2019/08/cannabis-edibles-G-1087610076.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: b14abd790fbca488710076499cdeb7007818b8f7f086adb43cef6c048cd8fa6c

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:19 GMT
last-modified: Wed, 14 Aug 2019 07:10:58 GMT
server: nginx
etag: "378314b423e24ecd4c18096e8ca3bd5c"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 34564
expires: Wed, 25 Sep 2019 04:31:19 GMT

GET
H2 200 hepctesthcvtestss3283803_1176754.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 189 KB
189 KB 384ms
383ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/hepctesthcvtestss3283803_1176754.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: a97daad205264b2064ddba0bcd5805a88516fd37337f3e747b68485891cdf139

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:19 GMT
last-modified: Wed, 20 Mar 2019 23:58:31 GMT
server: nginx
etag: "ef4025abd1be77cd5a8fa6ffb51bc132"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 193368
expires: Wed, 25 Sep 2019 04:31:19 GMT

GET
H2 200 supplementpillsbottlets_991666.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 188 KB
188 KB 106ms
100ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/supplementpillsbottlets_991666.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 1680079026ea2e28d50b62db83178bdbee0839f530ac643f123aa78f19725c28

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:19 GMT
last-modified: Thu, 21 Mar 2019 01:55:51 GMT
server: nginx
etag: "6eb4aef7488248e4a25cf6bda86838c7"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 192499
expires: Wed, 25 Sep 2019 04:31:19 GMT

GET
H2 200 ca0112pyelonephritis_221286.jpg
www.infectiousdiseaseadvisor.com/wp-content/uploads/sites/16/2019/07/ 42 KB
42 KB 1432ms
206ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.infectiousdiseaseadvisor.com/wp-content/uploads/sites/16/2019/07/ca0112pyelonephritis_221286.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 3a672cd0c63845154db58503128da661da16762ace08e250a221cdc49831e990

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:21 GMT
last-modified: Wed, 24 Jul 2019 07:12:05 GMT
server: nginx
etag: "f891ea510513d61c70ef6f1ac23326f7"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 42502
expires: Wed, 25 Sep 2019 04:31:21 GMT

GET
H2 200 atrialfibrillationclipboard_1158332.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 230 KB
231 KB 137ms
134ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/atrialfibrillationclipboard_1158332.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: cb91042c901aa1ea19c71c43fa1eb9aeff5c80b22726242b9eecbec7ff895faa

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:19 GMT
last-modified: Wed, 20 Mar 2019 19:51:37 GMT
server: nginx
etag: "a4ac8be17377e5cd30574e0c5983ac6f"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 236020
expires: Wed, 25 Sep 2019 04:31:19 GMT

GET
H2 200 imfinzi_1215044.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 396 KB
396 KB 108ms
107ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/imfinzi_1215044.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 397486cc51c9de9801c4edd9fb26b4ff81b25b770528ef43cd5ebebb6c541b13

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:19 GMT
last-modified: Wed, 20 Mar 2019 21:40:53 GMT
server: nginx
etag: "bcc532d51fe6cfece965d6933a3fb75f"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 405197
expires: Wed, 25 Sep 2019 04:31:19 GMT

GET
H2 200 inveltyspackagenskala_1520295.jpg
www.empr.com/wp-content/uploads/sites/7/2019/01/ 13 KB
13 KB 100ms
100ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2019/01/inveltyspackagenskala_1520295.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 7b9025bc821fe7e035dba945260d61e17a43699d25d06392182e81d0d565e455

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:19 GMT
last-modified: Wed, 20 Mar 2019 09:08:36 GMT
server: nginx
etag: "3f5e1c636a33868979996690f1b7b208"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 12912
expires: Wed, 25 Sep 2019 04:31:19 GMT

GET
H2 200 ecolins_1013597.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 175 KB
175 KB 99ms
99ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/ecolins_1013597.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 8bc773193e4ec261e72d77fdd742833d888896d519f801fa0e289e0880865238

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:19 GMT
last-modified: Thu, 21 Mar 2019 03:45:18 GMT
server: nginx
etag: "73a1f95cf6213c47de0a40337508f9cd"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 179176
expires: Wed, 25 Sep 2019 04:31:19 GMT

GET
H2 200 lupinlogons_950795.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 67 KB
67 KB 99ms
98ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/lupinlogons_950795.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 63df35f91cbcdaeaebd41e3612c181201e3b9a219c0cfb4e03390aa41aa3dbc0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:19 GMT
last-modified: Wed, 20 Mar 2019 23:41:12 GMT
server: nginx
etag: "408b27cf5a87831592c552b52e593a85"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 68374
expires: Wed, 25 Sep 2019 04:31:19 GMT

GET
H2 200 FDA-HQ-1.jpg
www.empr.com/wp-content/uploads/sites/7/2019/04/ 44 KB
44 KB 100ms
99ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2019/04/FDA-HQ-1.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 3622b951ea76b210435cfe0389822bfbeb3c690133e6c6fd4724c335b594420a

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:19 GMT
last-modified: Sun, 28 Apr 2019 07:11:12 GMT
server: nginx
etag: "281477ab9f7eb60e6b7d1f61e45fe582"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 45105
expires: Wed, 25 Sep 2019 04:31:19 GMT

GET
H2 200 482253doctorlaptopcomputer_964351.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 31 KB
32 KB 111ms
110ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/482253doctorlaptopcomputer_964351.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: d50a79836df0ebd32b0b0e885abd2b146a7bf523976656dc8c561ed8ea7163c5

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Wed, 20 Mar 2019 19:35:20 GMT
server: nginx
etag: "8d9af232e6e23b26ac923ab08bf2387d"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 32231
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 psilocybinmagicmushroomns_978492.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 175 KB
175 KB 100ms
100ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/psilocybinmagicmushroomns_978492.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 92957755d608d90013353d5141554c10d0a2d85e0f034563c442814f91a6b1d1

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Wed, 20 Mar 2019 19:41:08 GMT
server: nginx
etag: "eebbfb07e934d243b94f028232a657ca"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 178894
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 depressionmddg728909107_1410912.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 14 KB
14 KB 137ms
137ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/depressionmddg728909107_1410912.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 8ff24692e7395fae9138c4bb78c2bbb4d4923cae0d9f2720dee3a7e2d62d3a03

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Wed, 20 Mar 2019 21:42:15 GMT
server: nginx
etag: "223adb647bdda684b3b59babf32dd296"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 14347
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 gammaplex_1153190.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 63 KB
63 KB 131ms
130ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/gammaplex_1153190.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 74b2383559f4d24df752abd4bb58b9f4008df4f93abc423c105a5c0b0b42a848

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Wed, 20 Mar 2019 19:30:23 GMT
server: nginx
etag: "528d41c63d5a3ed561e495d1ec8e5f7e"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 64686
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 painmanagementipad_1123350.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 222 KB
223 KB 122ms
121ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/painmanagementipad_1123350.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 6003829935cc8575fbf4e925dace1c877be37ef8a64db4e4d36ba9cccb81ced8

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Wed, 20 Mar 2019 21:52:16 GMT
server: nginx
etag: "e10544aaa8142aad98c8f792023e6f75"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 227393
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 activatedplateletsg17259295_1466249.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 22 KB
22 KB 102ms
102ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/activatedplateletsg17259295_1466249.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 9d7f1238638cb9c3d4092a726046a39f5fbe62ee9b91df6c0e0741c31508302f

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Wed, 20 Mar 2019 21:56:03 GMT
server: nginx
etag: "6ee480cf359331bf7a75c880eff8af86"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 22623
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 traumaticbraininjuryss6116_1374600.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 26 KB
27 KB 130ms
129ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/traumaticbraininjuryss6116_1374600.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: b629a5806514c628428aa8f24a8897932dda5f7fdb588f66a9767cf62515970b

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Wed, 20 Mar 2019 22:09:16 GMT
server: nginx
etag: "54c50e7740e491937b446e85b6606e00"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 26885
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 483050manhandsgoutarthriti_965191.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 66 KB
66 KB 105ms
103ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/483050manhandsgoutarthriti_965191.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 6335784e52cf3e719e52018f534484f5c50fd02f59e1a5ad1f6a10a54659573e

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Thu, 21 Mar 2019 00:00:17 GMT
server: nginx
etag: "f0f0da63a5dd40b9ffee19868b5e62c8"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 67355
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 huntingtonsdiseasess572078_1257069.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 28 KB
28 KB 109ms
107ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/huntingtonsdiseasess572078_1257069.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 971e53838f5e7757386b22a96da2495c0ed12bc8daafed8aa647ed188ec82fed

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Wed, 20 Mar 2019 23:45:09 GMT
server: nginx
etag: "3e277f4e699d57baba5715e2bd4b9df5"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 28446
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 belviq_1477881.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 7 KB
7 KB 99ms
98ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/belviq_1477881.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: b0abfbbc3b3f06f000fddfb4069520bfc3c5f4d212baf76e0180076eafeb7f25

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Wed, 20 Mar 2019 21:55:29 GMT
server: nginx
etag: "0e75b424f96259ea05ac27b943f597f4"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 6907
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 FDA-orphan-drug-designation-granted.png
www.endocrinologyadvisor.com/wp-content/uploads/sites/9/2019/07/ 648 KB
649 KB 463ms
230ms Image
image/png 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.endocrinologyadvisor.com/wp-content/uploads/sites/9/2019/07/FDA-orphan-drug-designation-granted.png
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 85e3343d43fa9dc5c9cde01496f9800e72f07dfa6708432c0f682ec2066f71d3

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Tue, 30 Jul 2019 07:11:17 GMT
server: nginx
etag: "a1ea0386d99371270f0ce0119e8489af"
content-type: image/png
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 663594
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 dealogo_1360708.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 62 KB
63 KB 101ms
101ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/dealogo_1360708.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: ecb5a66c3beb8786964427668b1faea4b882a7a511f024004b4e58e3203ce39f

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Wed, 20 Mar 2019 21:59:58 GMT
server: nginx
etag: "674d6a062f3973def5b46a17eaf8c83c"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 63907
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 repathasureclickinjns_1498718.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 15 KB
15 KB 100ms
99ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/repathasureclickinjns_1498718.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: c30570f3c162ed8359e861510a1e4d445749c8eb0615482c7492e84fdf0a3629

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Wed, 20 Mar 2019 23:56:50 GMT
server: nginx
etag: "d8f4871e5abf6aca2214a0d72f69c883"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 15124
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 advilchildrengumflavorreca_1478497.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 45 KB
45 KB 143ms
142ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/advilchildrengumflavorreca_1478497.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: e01b08e5402a7e387b54b1f1bfe46f3aa2292c92032a338a1a65e28e58381432

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Thu, 21 Mar 2019 00:08:01 GMT
server: nginx
etag: "7eaca956c2bf678905f6530148d78e64"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 45769
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 genericro_969021.png
www.empr.com/wp-content/uploads/sites/7/2018/12/ 177 KB
177 KB 138ms
138ms Image
image/png 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/genericro_969021.png
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 8accf582ee904ff97dd0439d424181b266e8e55b781563fcd67ba5c1d29fc784

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Wed, 20 Mar 2019 23:38:12 GMT
server: nginx
etag: "2ed7f587711d0990fd099dfae036d29c"
content-type: image/png
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 181314
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 FDA-logo-FI.png
www.empr.com/wp-content/uploads/sites/7/2019/07/ 426 KB
427 KB 100ms
100ms Image
image/png 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2019/07/FDA-logo-FI.png
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 92f43f03582b5fa6ab35f37ba18f5e9b532fe6105c262a7ad0879bd1b3a565c7

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Sat, 10 Aug 2019 07:11:11 GMT
server: nginx
etag: "ebd14b1e1b6d11a26972094f1799ed78"
content-type: image/png
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 436575
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 fdabluero_1143576.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 74 KB
75 KB 100ms
99ms Image
image/jpeg 3.225.154.29
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.empr.com/wp-content/uploads/sites/7/2018/12/fdabluero_1143576.jpg
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 3.225.154.29 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS: ec2-3-225-154-29.compute-1.amazonaws.com
Software: nginx /
Resource Hash: 339cb69fecc1cd06a5fe7f29673ba4430ca24dcbab8a6556999919630fbc355e

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption: AES256
date: Mon, 26 Aug 2019 04:31:20 GMT
last-modified: Thu, 21 Mar 2019 01:52:24 GMT
server: nginx
etag: "68987ba85b744131475fce7b9659a8fa"
content-type: image/jpeg
status: 200
cache-control: max-age=2592000
accept-ranges: bytes
content-length: 76095
expires: Wed, 25 Sep 2019 04:31:20 GMT

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 4 KB
2 KB 77ms
77ms XHR
text/plain 216.58.207.34
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2554124751981206&correlator=1822689865900055&output=ldjh&callback=googletag.impl.pubads.callbackProxy1&impl=fif&adsid=NT&eid=21063965%2C21064324&vrg=2019081901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190826&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2FOOP_prestitial&sz=1x1&ists=1&scp=pos%3DOOP_prestitial&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DSteve%2520Duffy%26postID%3D122588%26env%3Dlive%26sid%3DDrugs_in_the_Pipeline%26styleid%3D%26cat%3DCystic_Fibrosis%252CInborn_Errors_Of_Metabolism%252CMetabolic_Disorders%252CRespiratory_Diseases%252FDisorders%26atype%3DMPR_Drug_News%26block%3Dmpr_basaglar042616%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie_enabled=1&bc=31&abxe=1&lmt=1566793877&dt=1566793877398&dlt=1566793872426&idt=3925&frm=20&biw=1585&bih=1200&oid=3&adx=0&ady=3592&adk=2574155320&uci=1&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&dssz=78&icsg=38070590111748&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1585x3592&msz=1585x1&blev=1&bisch=1&ga_vid=1510935939.1566793877&ga_sid=1566793877&ga_hid=1307723831&fws=4&ohw=1585

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s24-in-f2.1e100.net

Software

cafe /

Resource Hash

186de9ad0b00ebb4b4c869b249473d1f6d94cae531da0b8293a9447fb5d46ce1

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:17 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 2199
x-xss-protection: 0
google-lineitem-id: 132788185
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: 138274708445
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.empr.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 pubads_impl_rendering_2019081901.js Show response
securepubads.g.doubleclick.net/gpt/ 66 KB
25 KB 42ms
42ms Script
text/javascript 216.58.207.34
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s24-in-f2.1e100.net

Software

sffe /

Resource Hash

a9f4ae6b4905f74dfe7fb7fce1fc8ee328d1d1d085a783257fed1f970c0d9b72

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:20 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Mon, 19 Aug 2019 13:05:42 GMT
server: sffe
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, immutable, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 25389
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:20 GMT

GET container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/ 0
0

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 20 KB
6 KB 180ms
180ms XHR
text/plain 216.58.207.34
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2554124751981206&correlator=1822689865900055&output=ldjh&callback=googletag.impl.pubads.callbackProxy2&impl=fif&adsid=NT&eid=21063965%2C21064324&vrg=2019081901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190826&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Fleaderboard_top&sz=728x90&scp=pos%3Dleaderboard_top&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DSteve%2520Duffy%26postID%3D122588%26env%3Dlive%26sid%3DDrugs_in_the_Pipeline%26styleid%3D%26cat%3DCystic_Fibrosis%252CInborn_Errors_Of_Metabolism%252CMetabolic_Disorders%252CRespiratory_Diseases%252FDisorders%26atype%3DMPR_Drug_News%26block%3Dmpr_basaglar042616%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie_enabled=1&bc=31&abxe=1&lmt=1566793878&dt=1566793878180&dlt=1566793872426&idt=3925&frm=20&biw=1585&bih=1200&oid=3&adx=193&ady=140&adk=3073216299&uci=2&ifi=2&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&dssz=79&icsg=38070590111748&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1200x-1&msz=1200x-1&blev=1&bisch=1&ga_vid=1510935939.1566793877&ga_sid=1566793877&ga_hid=1307723831&fws=516&ohw=1585

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s24-in-f2.1e100.net

Software

cafe /

Resource Hash

7e0a2a49e63a0f7098d93c8d24fef6146e219354cd290a3754fbca3f3905f314

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:18 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 5813
x-xss-protection: 0
google-lineitem-id: 132783265
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: 116494044025
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.empr.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET universal-tag.js
ads.spotible.com/tag/ Frame A22F 0
0

GET
DATA 200
OK truncated
/ Frame A22F 215 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 16ee52743898a9621045d3f55f47084f6acfc8c9b215ccf71431998c3ddaac5f

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type: image/png

GET
H2 200 view Show response
securepubads.g.doubleclick.net/pcs/ Frame B3E0 0
144 B 44ms
44ms Fetch
image/gif 216.58.207.34
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstNZUe6Vwj3iAXiTGDsMCw4XTJUBf7hrkTucM_P3dC6zQqlZwiy3Cs0ADuJKFijKRu-UKN2DVWxR5NU3HYBAlT725hSzcdtu8pto0nDvlQucfh_lL5a0dBkTvA82oqs5aVUxUJg7lCUiHkzfZ0ESxDVj5R_WHf2VT-OhISDJdMwqZvvbWkPWGxNTxAIL5Uq3-_0xytuDG-7JzV4ILT-7pQZhewi0clwERnHRMCdKAx9eQYAytv9kE7rRqvpjxqy4w9QQlxZ7d3D87Wez06W9g2UI2bXO7pFCaZ7DZPcHlWsIOTnpSenTYc&sig=Cg0ArKJSzEnlymmOeD0VEAE&adurl=

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s24-in-f2.1e100.net

Software

cafe /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin: *
date: Mon, 26 Aug 2019 04:31:20 GMT
x-content-type-options: nosniff
server: cafe
status: 200
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin: *
cache-control: private
content-type: image/gif
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 0
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:20 GMT

GET
H2 200 window_focus.js Show response
tpc.googlesyndication.com/pagead/js/r20190821/r20110914/client/ Frame B3E0 2 KB
1 KB 6ms
5ms Script
text/javascript 2a00:1450:4001:806::2001
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/pagead/js/r20190821/r20110914/client/window_focus.js

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

6dd7e7ea596e944778e78ccd97a2e17837ef633d69cad2108842d4ddcb958b1c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Sun, 25 Aug 2019 01:22:18 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 97742
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
content-disposition: attachment; filename="f.txt"
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 1054
x-xss-protection: 0
server: cafe
etag: 18205873578609640656
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
cache-control: public, max-age=1209600
timing-allow-origin: *
expires: Sun, 08 Sep 2019 01:22:18 GMT

GET
H2 200 osd_listener.js Show response
www.googletagservices.com/activeview/js/current/ Frame B3E0 75 KB
28 KB 13ms
13ms Script
text/javascript 2a00:1450:4001:818::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

99019b305dcd9c03e496cf964097ae47afd65407cd9b26840e05d50560a41169

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:20 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "1566558908912117"
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, max-age=3000
accept-ranges: bytes
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length: 28532
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:20 GMT

GET
H2 200 init-132dn9au2z77uqg0m5w.js Show response
api.b2c.com/api/ Frame B3E0 12 KB
5 KB 548ms
183ms Script
text/javascript 2600:1f14:e96:5800:e914:8d8d:e7fd:f63e
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21799854605&AdvertiserID=27496345&OrderID=415436905&LineItemID=132783265&CreativeID=116494044025&CPN=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&sid=Drugs_in_the_Pipeline
Requested by: Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:1f14:e96:5800:e914:8d8d:e7fd:f63e Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: openresty /
Resource Hash: 809a11b0aa3dcc2a3886f7c8facbda7be905bd93dbafa71af3c5ea85dfbe1c2e

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:21 GMT
content-encoding: gzip
server: openresty
content-type: text/javascript
status: 200
cache-control: no-cache, no-store, must-revalidate
expires: -1

GET
H2 200 5536585125677552591
tpc.googlesyndication.com/simgad/ Frame B3E0 68 KB
68 KB 7ms
7ms Image
image/jpeg 2a00:1450:4001:806::2001
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://tpc.googlesyndication.com/simgad/5536585125677552591

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

3a9b25967ee1a016b7bd6cff12850cfa623efc42ea5333d27fa71735eb476969

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Fri, 23 Aug 2019 05:31:55 GMT
x-content-type-options: nosniff
age: 255565
x-dns-prefetch-control: off
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 69914
x-xss-protection: 0
last-modified: Thu, 02 Feb 2017 14:46:42 GMT
server: sffe
content-type: image/jpeg
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sat, 22 Aug 2020 05:31:55 GMT

GET
H2 200 osd.js Show response
www.googletagservices.com/activeview/js/current/ 75 KB
28 KB 16ms
14ms Script
text/javascript 2a00:1450:4001:818::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

f876042041fbf3fd3ca277c5bc8d70ae5a82769a34e186a2b7cb3b7357c52c77

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:21 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "1566558908912117"
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, max-age=3000
accept-ranges: bytes
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length: 28364
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:21 GMT

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 20 KB
6 KB 157ms
157ms XHR
text/plain 216.58.207.34
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2554124751981206&correlator=1822689865900055&output=ldjh&callback=googletag.impl.pubads.callbackProxy3&impl=fif&adsid=NT&eid=21063965%2C21064324&vrg=2019081901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190826&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Fbox_1&sz=300x250%7C300x600&scp=pos%3Dbox_1%26lid%3D132783265&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DSteve%2520Duffy%26postID%3D122588%26env%3Dlive%26sid%3DDrugs_in_the_Pipeline%26styleid%3D%26cat%3DCystic_Fibrosis%252CInborn_Errors_Of_Metabolism%252CMetabolic_Disorders%252CRespiratory_Diseases%252FDisorders%26atype%3DMPR_Drug_News%26block%3Dmpr_basaglar042616%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3D6362604030fc2644%3AT%3D1566793878%3AS%3DALNI_MZyR7_b3G_yJvrgXjuUYka8_ATqLw&cookie_enabled=1&bc=31&abxe=1&lmt=1566793880&dt=1566793880851&dlt=1566793872426&idt=3925&frm=20&biw=1585&bih=1200&oid=3&adx=1053&ady=305&adk=2374356963&uci=3&ifi=3&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&dssz=78&icsg=38070590111748&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x250&msz=300x250&blev=1&bisch=1&psts=CjQI2d-oP-gB3bfCjoMEggIasbmAD9G59iGBw_Yh8e3PNIrE_ZpR_cX9mlHRAvYfJiKMZhwo%2CCjQIobmoP-gB-ZbY_LEDggIasbmAD9G59iGBw_Yh8e3PNIrE_ZpRjcT9mlHRAjQbgdB2Q4vK&ga_vid=1510935939.1566793877&ga_sid=1566793877&ga_hid=1307723831&fws=516&ohw=1585

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s24-in-f2.1e100.net

Software

cafe /

Resource Hash

b3d596b33a08d5bb812d293d15743b253cace8d30ebc3b2e6ef946fd8227650c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:20 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 5825
x-xss-protection: 0
google-lineitem-id: 5144421111
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: 138278274593
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.empr.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
DATA 200
OK truncated
/ Frame B3E0 213 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 43a7de7729ea62e1c4936bace7c05deb0c61b69ef90650608bf6e2851e1a93b1

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type: image/png

GET
H2 200 view Show response
securepubads.g.doubleclick.net/pcs/ Frame BDFE 0
282 B 44ms
43ms Fetch
image/gif 216.58.207.34
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjss3X9IWLbI6iBf0vEBVyOES0vd5rHvSdWDP-oeAQNg99AkvT8zmeY1PLYvjjne5c7ml5WK-8Ws8b0eYhCtKcS8-23QZwlCxuom5FiiHDGj5UiRQtdltur3Aac_CCrLPyZR-Q3Kymq0gA-itr4YdZddYyLzfnK5K7NDfP_wgvgjpOj5gNR0JVgYS33QxGEhUVEVE166Ka0vgb4K10locmKY034DiUIUkjbeT48zMtmrVew9bpyDNLVh4j4GXDKVfcYhhx2A5k0sgnzUfMbEqw0XpsBbsLWZrQCtfKwnibHU&sai=AMfl-YQV04f8agt5z-ZyljET_4GYnlv-YzzkxNBJtrjM2fP24rk9BI1YxXlJA6HmFZJVrv6dLoj924Mu5O2v96p5N_gmXMYhVSb9i4oIE7u2&sig=Cg0ArKJSzHxbqYB20tXVEAE&adurl=

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s24-in-f2.1e100.net

Software

cafe /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin: *
date: Mon, 26 Aug 2019 04:31:21 GMT
x-content-type-options: nosniff
server: cafe
status: 200
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin: *
cache-control: private
content-type: image/gif
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 0
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:21 GMT

GET
H2 200 window_focus.js Show response
tpc.googlesyndication.com/pagead/js/r20190821/r20110914/client/ Frame BDFE 2 KB
1 KB 11ms
7ms Script
text/javascript 2a00:1450:4001:806::2001
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/pagead/js/r20190821/r20110914/client/window_focus.js

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

6dd7e7ea596e944778e78ccd97a2e17837ef633d69cad2108842d4ddcb958b1c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Sun, 25 Aug 2019 01:22:18 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 97743
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
content-disposition: attachment; filename="f.txt"
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 1054
x-xss-protection: 0
server: cafe
etag: 18205873578609640656
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
cache-control: public, max-age=1209600
timing-allow-origin: *
expires: Sun, 08 Sep 2019 01:22:18 GMT

GET
H2 200 osd_listener.js Show response
www.googletagservices.com/activeview/js/current/ Frame BDFE 75 KB
28 KB 14ms
13ms Script
text/javascript 2a00:1450:4001:818::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

99019b305dcd9c03e496cf964097ae47afd65407cd9b26840e05d50560a41169

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:21 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "1566558908912117"
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, max-age=3000
accept-ranges: bytes
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length: 28532
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:21 GMT

GET
H2 200 init-132dn9au2z77uqg0m5w.js Show response
api.b2c.com/api/ Frame BDFE 12 KB
5 KB 183ms
181ms Script
text/javascript 2600:1f14:e96:5800:e914:8d8d:e7fd:f63e
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21799854830&AdvertiserID=27496345&OrderID=415436905&LineItemID=5144421111&CreativeID=138278274593&CPN=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&sid=Drugs_in_the_Pipeline
Requested by: Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:1f14:e96:5800:e914:8d8d:e7fd:f63e Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: openresty /
Resource Hash: 12702fd02cf93bf91f8e5cf296a33ae6421bb4eb61adedbf71b96b4d7e557284

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:21 GMT
content-encoding: gzip
server: openresty
content-type: text/javascript
status: 200
cache-control: no-cache, no-store, must-revalidate
expires: -1

GET
H2 200 4489233149016687223
tpc.googlesyndication.com/simgad/ Frame BDFE 41 KB
41 KB 7ms
7ms Image
image/png 2a00:1450:4001:806::2001
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://tpc.googlesyndication.com/simgad/4489233149016687223

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

f984c8e1978cf73d7c628f6d255ced232aab616cd77fcf720d5afb6b98fe4725

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Sat, 24 Aug 2019 15:07:56 GMT
x-content-type-options: nosniff
age: 134605
x-dns-prefetch-control: off
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 42317
x-xss-protection: 0
last-modified: Wed, 07 Aug 2019 16:56:46 GMT
server: sffe
content-type: image/png
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sun, 23 Aug 2020 15:07:56 GMT

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 20 KB
6 KB 205ms
205ms XHR
text/plain 216.58.207.34
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2554124751981206&correlator=1822689865900055&output=ldjh&callback=googletag.impl.pubads.callbackProxy4&impl=fif&adsid=NT&eid=21063965%2C21064324&vrg=2019081901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190826&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Fbox_2&sz=300x250&scp=pos%3Dbox_2%26lid%3D132783265%2C5144421111&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DSteve%2520Duffy%26postID%3D122588%26env%3Dlive%26sid%3DDrugs_in_the_Pipeline%26styleid%3D%26cat%3DCystic_Fibrosis%252CInborn_Errors_Of_Metabolism%252CMetabolic_Disorders%252CRespiratory_Diseases%252FDisorders%26atype%3DMPR_Drug_News%26block%3Dmpr_basaglar042616%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3D6362604030fc2644%3AT%3D1566793878%3AS%3DALNI_MZyR7_b3G_yJvrgXjuUYka8_ATqLw&cookie_enabled=1&bc=31&abxe=1&lmt=1566793881&dt=1566793881039&dlt=1566793872426&idt=3925&frm=20&biw=1585&bih=1200&oid=3&adx=1053&ady=826&adk=2198966543&uci=4&ifi=4&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-hay-20190826%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-65947-2303653&dssz=78&icsg=38070590111748&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x283&msz=300x250&blev=1&bisch=1&psts=CjUI98WGlRPoAaGMnJCDBIICGrG5gA_RufYhgcP2IfHtzzSKxP2aUe7F_ZpR0QL5B9qkoO3vrg%2CCjQI2d-oP-gB3bfCjoMEggIasbmAD9G59iGBw_Yh8e3PNIrE_ZpR_cX9mlHRAvYfJiKMZhwo%2CCjQIobmoP-gB-ZbY_LEDggIasbmAD9G59iGBw_Yh8e3PNIrE_ZpRjcT9mlHRAjQbgdB2Q4vK&ga_vid=1510935939.1566793877&ga_sid=1566793877&ga_hid=1307723831&fws=516&ohw=1585

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s24-in-f2.1e100.net

Software

cafe /

Resource Hash

1a6125ac66daf1a79e6232c9d119c0deb10b71afe62e9cdfed20971cf0b54d2d

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:21 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 5798
x-xss-protection: 0
google-lineitem-id: 5144421111
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: 138278574775
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.empr.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
DATA 200
OK truncated
/ Frame BDFE 213 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 59db9009e6ada2df081551615ec28a313d1a53edf9e833cba4e098038e87bef7

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type: image/png

POST
H2 200 / Show response
adtrackapi.haymarketmedia.com/adverttracking/ 2 B
367 B 178ms
178ms XHR
application/json 2600:9000:2057:1e00:16:bc48:4dc0:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by: Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:2057:1e00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: /
Resource Hash: 44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type: application/json

Response headers

date: Mon, 26 Aug 2019 04:31:21 GMT
via: 1.1 71b147cd3102755b55ba8b6fd34e3f4a.cloudfront.net (CloudFront)
x-amz-cf-pop: FRA6-C1
x-amzn-requestid: 5ac97ff7-c7ba-11e9-a8fb-fb7fe9815593
status: 200
x-cache: Miss from cloudfront
content-type: application/json
access-control-allow-origin: *
x-amzn-trace-id: Root=1-5d636099-03c5cae4df633864fedc0964;Sampled=0
x-amz-apigw-id: fAwH8Fd1oAMFWBw=
content-length: 2
x-amz-cf-id: G5C8jHljdozktxHpuk7l7BYwZ0l_ZsrWBPk9_2pxJHIyj8PDhAGFTw==

POST
H2 200 / Show response
adtrackapi.haymarketmedia.com/adverttracking/ 2 B
367 B 358ms
358ms XHR
application/json 2600:9000:2057:1e00:16:bc48:4dc0:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by: Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:2057:1e00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: /
Resource Hash: 44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type: application/json

Response headers

date: Mon, 26 Aug 2019 04:31:21 GMT
via: 1.1 71b147cd3102755b55ba8b6fd34e3f4a.cloudfront.net (CloudFront)
x-amz-cf-pop: FRA6-C1
x-amzn-requestid: 5ae3be59-c7ba-11e9-a6a2-7b5af2495148
status: 200
x-cache: Miss from cloudfront
content-type: application/json
access-control-allow-origin: *
x-amzn-trace-id: Root=1-5d636099-1aa2a1fe20be2db008cba876;Sampled=0
x-amz-apigw-id: fAwH-HCVoAMFj1g=
content-length: 2
x-amz-cf-id: VFYJqcR_84XwxJ_NKk6szDUE51eAGjPoaL-2CcYfkpq-pUjXTGkaSA==

GET
H2 200 view Show response
securepubads.g.doubleclick.net/pcs/ Frame 3EE9 0
62 B 46ms
44ms Fetch
image/gif 216.58.207.34
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsskNEukyTeFb-_aUW2PnZrLM4yLREUAgnyW90lk3nozX339R9yXuGLQGgUsXgJ4atk0sOr9AXW7Tb7HtmCjTGNoK5ad7z1AsIKywmtJFa0yCfYV25P0CjUuoOQS2aeHGXUOQ-dGXhv2WOUHdlgyCBcx4XMC1xuHRzd7rE2_vj0CGYNd8CoshO856LImf9zi9yluvz-dfw6fzBQvi2dyxc6wupr1s45MNBjvH-UV-O3bggxTn2XassCN2uIGjVCR4UrFNhRg7MPAY9jaXtFxElwTqgy6NC-hVgd6IuH76qw&sig=Cg0ArKJSzFl3CMdrDeueEAE&adurl=

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s24-in-f2.1e100.net

Software

cafe /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin: *
date: Mon, 26 Aug 2019 04:31:21 GMT
x-content-type-options: nosniff
server: cafe
status: 200
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin: *
cache-control: private
content-type: image/gif
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 0
x-xss-protection: 0

GET
H2 200 4489233149016687223
tpc.googlesyndication.com/simgad/ Frame 3EE9 41 KB
41 KB 7ms
5ms Image
image/png 2a00:1450:4001:806::2001
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://tpc.googlesyndication.com/simgad/4489233149016687223

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

f984c8e1978cf73d7c628f6d255ced232aab616cd77fcf720d5afb6b98fe4725

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Sat, 24 Aug 2019 15:07:56 GMT
x-content-type-options: nosniff
age: 134605
x-dns-prefetch-control: off
status: 200
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 42317
x-xss-protection: 0
last-modified: Wed, 07 Aug 2019 16:56:46 GMT
server: sffe
content-type: image/png
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sun, 23 Aug 2020 15:07:56 GMT

GET
H2 200 window_focus.js Show response
tpc.googlesyndication.com/pagead/js/r20190821/r20110914/client/ Frame 3EE9 2 KB
1 KB 8ms
6ms Script
text/javascript 2a00:1450:4001:806::2001
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/pagead/js/r20190821/r20110914/client/window_focus.js

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

6dd7e7ea596e944778e78ccd97a2e17837ef633d69cad2108842d4ddcb958b1c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Sun, 25 Aug 2019 01:22:18 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 97743
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
content-disposition: attachment; filename="f.txt"
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 1054
x-xss-protection: 0
server: cafe
etag: 18205873578609640656
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
cache-control: public, max-age=1209600
timing-allow-origin: *
expires: Sun, 08 Sep 2019 01:22:18 GMT

GET
H2 200 osd_listener.js Show response
www.googletagservices.com/activeview/js/current/ Frame 3EE9 75 KB
28 KB 14ms
13ms Script
text/javascript 2a00:1450:4001:818::2002
Google LLC

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

sffe /

Resource Hash

99019b305dcd9c03e496cf964097ae47afd65407cd9b26840e05d50560a41169

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date: Mon, 26 Aug 2019 04:31:21 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "1566558908912117"
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, max-age=3000
accept-ranges: bytes
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length: 28532
x-xss-protection: 0
expires: Mon, 26 Aug 2019 04:31:21 GMT

GET
H2 204 l
www.google.com/ads/measurement/ Frame 3EE9 0
0 14ms
13ms Image
text/html 2a00:1450:4001:820::2004
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.google.com/ads/measurement/l?ebcid=ALh7CaT8kNHLdnVtJPsnQYE0T8aSpb_jTo0Ht6VZB878-M1YzcHHTzzKK9Yfi51JnHhh6bruvnoOvnU99Kvf0_sJ_UXjTjRBcw
Requested by: Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a00:1450:4001:820::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

GET
H2 200 init-132dn9au2z77uqg0m5w.js Show response
api.b2c.com/api/ Frame 3EE9 12 KB
5 KB 303ms
302ms Script
text/javascript 2600:1f14:e96:5800:e914:8d8d:e7fd:f63e
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21799854854&AdvertiserID=27496345&OrderID=415436905&LineItemID=5144421111&CreativeID=138278574775&CPN=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&sid=Drugs_in_the_Pipeline
Requested by: Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019081901.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:1f14:e96:5800:e914:8d8d:e7fd:f63e Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: openresty /
Resource Hash: d989c7c0a0111c37099675429fed2a6a04faddfaf88627d35642ed14bcca3c41

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:21 GMT
content-encoding: gzip
server: openresty
content-type: text/javascript
status: 200
cache-control: no-cache, no-store, must-revalidate
expires: -1

POST
H2 200 / Show response
adtrackapi.haymarketmedia.com/adverttracking/ 2 B
366 B 448ms
448ms XHR
application/json 2600:9000:2057:1e00:16:bc48:4dc0:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by: Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:2057:1e00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: /
Resource Hash: 44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type: application/json

Response headers

date: Mon, 26 Aug 2019 04:31:21 GMT
via: 1.1 71b147cd3102755b55ba8b6fd34e3f4a.cloudfront.net (CloudFront)
x-amz-cf-pop: FRA6-C1
x-amzn-requestid: 5b0e50f5-c7ba-11e9-a5be-a52bc80db4d5
status: 200
x-cache: Miss from cloudfront
content-type: application/json
access-control-allow-origin: *
x-amzn-trace-id: Root=1-5d636099-e9c62aecb8fc301e48ad8f14;Sampled=0
x-amz-apigw-id: fAwIBHqdoAMFdnQ=
content-length: 2
x-amz-cf-id: _37W-kpdfxppWSi_5fp0ZMpKhkzoPs0CArUKTNNMK6fQQ44pc3qxDg==

GET
DATA 200
OK truncated
/ Frame 3EE9 216 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: ea5f698bd255afc7b0955d5c9a784fd06775b9bc70474578d83821f260559a1e

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type: image/png

GET
H/1.1 200
OK ad.gif
api-54-218-116-18.b2c.com/api/ Frame B3E0 43 B
233 B 510ms
170ms Image
image/gif 2600:1f14:e96:5800:bf44:2e7b:f554:ed7b
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://api-54-218-116-18.b2c.com/api/ad.gif
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:1f14:e96:5800:bf44:2e7b:f554:ed7b Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: openresty /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Mon, 26 Aug 2019 04:31:21 GMT
Last-Modified: Mon, 28 Sep 1970 06:00:00 GMT
Server: openresty
Connection: keep-alive
Content-Length: 43
Content-Type: image/gif

POST
H2 200 / Show response
adtrackapi.haymarketmedia.com/adverttracking/ 2 B
366 B 445ms
444ms XHR
application/json 2600:9000:2057:1e00:16:bc48:4dc0:93a1
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by: Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:9000:2057:1e00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: /
Resource Hash: 44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode: cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type: application/json

Response headers

date: Mon, 26 Aug 2019 04:31:22 GMT
via: 1.1 71b147cd3102755b55ba8b6fd34e3f4a.cloudfront.net (CloudFront)
x-amz-cf-pop: FRA6-C1
x-amzn-requestid: 5b59635f-c7ba-11e9-a371-b1864a28f057
status: 200
x-cache: Miss from cloudfront
content-type: application/json
access-control-allow-origin: *
x-amzn-trace-id: Root=1-5d63609a-68e029eb70d1462f4ed498bf;Sampled=0
x-amz-apigw-id: fAwIFHkUIAMFV-w=
content-length: 2
x-amz-cf-id: ctYDEcq8khIq298-Dp4bFyL8YmoAlmePPIy3LB9q4th221qCeOR_iw==

GET
H/1.1 200
OK ad.gif
api-34-210-86-189.b2c.com/api/ Frame BDFE 43 B
233 B 525ms
176ms Image
image/gif 2600:1f14:e96:5802:dbba:9f1a:1862:a442
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://api-34-210-86-189.b2c.com/api/ad.gif
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:1f14:e96:5802:dbba:9f1a:1862:a442 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: openresty /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Mon, 26 Aug 2019 04:31:22 GMT
Last-Modified: Mon, 28 Sep 1970 06:00:00 GMT
Server: openresty
Connection: keep-alive
Content-Length: 43
Content-Type: image/gif

GET
H/1.1 200
OK ad.gif
api-54-218-116-18.b2c.com/api/ Frame 3EE9 43 B
233 B 500ms
169ms Image
image/gif 2600:1f14:e96:5800:bf44:2e7b:f554:ed7b
Amazon.com

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://api-54-218-116-18.b2c.com/api/ad.gif
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:1f14:e96:5800:bf44:2e7b:f554:ed7b Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: openresty /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date: Mon, 26 Aug 2019 04:31:22 GMT
Last-Modified: Mon, 28 Sep 1970 06:00:00 GMT
Server: openresty
Connection: keep-alive
Content-Length: 43
Content-Type: image/gif

GET
H/1.1

200
OK

4 Show response
api-54-218-116-18.b2c.com/api/ Frame B3E0
Redirect Chain

https://api-54-218-116-18.b2c.com/api/x?FHwzu1TA4iqLeKle$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2RydWdzLWluLXRoZS1waXBlbGluZS9mZGEtdG8tcmV2aWV3LWVsZXhhY2FmdG9yLXRlemFjYWZ0b3ItaXZhY2FmdG9y...
https://api-54-218-116-18.b2c.com:444/api/4?FHwzu1TA4iqLeKle

43 B
441 B

1720ms
173ms

XHR
image/gif

54.218.116.18
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://api-54-218-116-18.b2c.com:444/api/4?FHwzu1TA4iqLeKle
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 54.218.116.18 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: ec2-54-218-116-18.us-west-2.compute.amazonaws.com
Software: openresty /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma: no-cache
Date: Mon, 26 Aug 2019 04:31:23 GMT
Last-Modified: Mon, 28 Sep 1970 06:00:00 GMT
Server: openresty
Access-Control-Allow-Methods: GET, POST, OPTIONS
Content-Type: image/gif
Access-Control-Allow-Origin: null
Cache-Control: no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Length: 43
Expires: -1

Redirect headers

Date: Mon, 26 Aug 2019 04:31:22 GMT
Server: openresty
Location: https://api-54-218-116-18.b2c.com:444/api/4?FHwzu1TA4iqLeKle
Access-Control-Allow-Methods: GET, POST, OPTIONS
Content-Type: text/html
Access-Control-Allow-Origin: https://www.empr.com
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Length: 142

GET
H/1.1

200
OK

4 Show response
api-34-210-86-189.b2c.com/api/ Frame BDFE
Redirect Chain

https://api-34-210-86-189.b2c.com/api/x?X2DDXQsU7BzW334P$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2RydWdzLWluLXRoZS1waXBlbGluZS9mZGEtdG8tcmV2aWV3LWVsZXhhY2FmdG9yLXRlemFjYWZ0b3ItaXZhY2FmdG9y...
https://api-34-210-86-189.b2c.com:444/api/4?X2DDXQsU7BzW334P

43 B
441 B

7984ms
178ms

XHR
image/gif

34.210.86.189
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://api-34-210-86-189.b2c.com:444/api/4?X2DDXQsU7BzW334P
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 34.210.86.189 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: ec2-34-210-86-189.us-west-2.compute.amazonaws.com
Software: openresty /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma: no-cache
Date: Mon, 26 Aug 2019 04:31:30 GMT
Last-Modified: Mon, 28 Sep 1970 06:00:00 GMT
Server: openresty
Access-Control-Allow-Methods: GET, POST, OPTIONS
Content-Type: image/gif
Access-Control-Allow-Origin: null
Cache-Control: no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Length: 43
Expires: -1

Redirect headers

Date: Mon, 26 Aug 2019 04:31:22 GMT
Server: openresty
Location: https://api-34-210-86-189.b2c.com:444/api/4?X2DDXQsU7BzW334P
Access-Control-Allow-Methods: GET, POST, OPTIONS
Content-Type: text/html
Access-Control-Allow-Origin: https://www.empr.com
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Length: 142

GET
H/1.1

200
OK

4 Show response
api-54-218-116-18.b2c.com/api/ Frame 3EE9
Redirect Chain

https://api-54-218-116-18.b2c.com/api/x?dfaPWmTvOg140xr8$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2RydWdzLWluLXRoZS1waXBlbGluZS9mZGEtdG8tcmV2aWV3LWVsZXhhY2FmdG9yLXRlemFjYWZ0b3ItaXZhY2FmdG9y...
https://api-54-218-116-18.b2c.com:444/api/4?dfaPWmTvOg140xr8

43 B
441 B

1718ms
172ms

XHR
image/gif

54.218.116.18
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://api-54-218-116-18.b2c.com:444/api/4?dfaPWmTvOg140xr8
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 54.218.116.18 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS: ec2-54-218-116-18.us-west-2.compute.amazonaws.com
Software: openresty /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma: no-cache
Date: Mon, 26 Aug 2019 04:31:23 GMT
Last-Modified: Mon, 28 Sep 1970 06:00:00 GMT
Server: openresty
Access-Control-Allow-Methods: GET, POST, OPTIONS
Content-Type: image/gif
Access-Control-Allow-Origin: null
Cache-Control: no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Length: 43
Expires: -1

Redirect headers

Date: Mon, 26 Aug 2019 04:31:22 GMT
Server: openresty
Location: https://api-54-218-116-18.b2c.com:444/api/4?dfaPWmTvOg140xr8
Access-Control-Allow-Methods: GET, POST, OPTIONS
Content-Type: text/html
Access-Control-Allow-Origin: https://www.empr.com
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Length: 142

POST
H/1.1 200
OK x
api-54-218-116-18.b2c.com/api/ Frame B3E0 0
382 B 180ms
180ms Other
text/plain 2600:1f14:e96:5800:bf44:2e7b:f554:ed7b
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://api-54-218-116-18.b2c.com/api/x?FHwzu1TA4iqLeKle$YWRibG9jayQ1MzAkMA
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:1f14:e96:5800:bf44:2e7b:f554:ed7b Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: openresty /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

Pragma: no-cache
Date: Mon, 26 Aug 2019 04:31:22 GMT
Server: openresty
Transfer-Encoding: chunked
Access-Control-Allow-Methods: GET, POST, OPTIONS
Content-Type: text/plain
Access-Control-Allow-Origin: https://www.empr.com
Cache-Control: no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Expires: -1

POST
H/1.1 200
OK x
api-54-218-116-18.b2c.com/api/ Frame 3EE9 0
382 B 170ms
169ms Other
text/plain 2600:1f14:e96:5800:bf44:2e7b:f554:ed7b
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://api-54-218-116-18.b2c.com/api/x?dfaPWmTvOg140xr8$YWRibG9jayQ1MTAkMA
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:1f14:e96:5800:bf44:2e7b:f554:ed7b Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: openresty /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

Pragma: no-cache
Date: Mon, 26 Aug 2019 04:31:22 GMT
Server: openresty
Transfer-Encoding: chunked
Access-Control-Allow-Methods: GET, POST, OPTIONS
Content-Type: text/plain
Access-Control-Allow-Origin: https://www.empr.com
Cache-Control: no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Expires: -1

POST
H/1.1 200
OK x
api-34-210-86-189.b2c.com/api/ Frame BDFE 0
382 B 537ms
178ms Other
text/plain 2600:1f14:e96:5802:dbba:9f1a:1862:a442
Amazon.com

General

Check archive.org

Show headers Download Go to

Full URL: https://api-34-210-86-189.b2c.com/api/x?X2DDXQsU7BzW334P$YWRibG9jayQ1MzgkMA
Requested by: Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 2600:1f14:e96:5802:dbba:9f1a:1862:a442 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software: openresty /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

Pragma: no-cache
Date: Mon, 26 Aug 2019 04:31:22 GMT
Server: openresty
Transfer-Encoding: chunked
Access-Control-Allow-Methods: GET, POST, OPTIONS
Content-Type: text/plain
Access-Control-Allow-Origin: https://www.empr.com
Cache-Control: no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials: true
Connection: keep-alive
Expires: -1

GET
H2 200 activeview
pagead2.googlesyndication.com/pcs/ Frame B3E0 42 B
110 B 42ms
42ms Image
image/gif 216.58.207.66
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsvpGSxsODi3uKZxTW56FteRxobGmgmtYqVr0AIssNmbpWi7iWXsCSAVIPGlRDF7XBQfXnI_qFEVVkK5fPxDdiOh3xTiCKsFMwZ_77Dtq2E&sig=Cg0ArKJSzDJUaI9EjXI2EAE&adk=3073216299&tt=-1&bs=1585%2C1200&mtos=1065,1065,1065,1065,1065&tos=1065,0,0,0,0&p=140,428.5,230,1156.5&mcvt=1065&rs=3&ht=0&tfs=129&tls=1194&mc=1&lte=1&bas=0&bac=0&met=0&avms=nio&niot_obs=12&niot_cbk=21&md=2&rst=1566793880844&rpt=537&isd=0&msd=0&lm=2&oseid=3&xdi=0&ps=1585%2C3683&ss=1600%2C1200&pt=-1&bin=1&deb=1-4-4-12-13-16-53-11-0-0-0&tvt=1186&r=v&id=osdim&vs=4&uc=13&upc=11&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=728x90&itpl=3&v=20190823

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.66 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s25-in-f2.1e100.net

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:22 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
status: 200
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin: *
cache-control: no-cache, must-revalidate
content-type: image/gif
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 activeview
pagead2.googlesyndication.com/pcs/ Frame BDFE 42 B
110 B 42ms
42ms Image
image/gif 216.58.207.66
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstywLhna_Q3D9ARbIiy53dBjS0_Wm334SaNz2bNe9LTCTBBmkoF5z6JnAw2XR6cAOevb0iGjFA5Qt29Xq16J-5Poo3sfBs0OQwAK8GyMIE&sig=Cg0ArKJSzBR_vtppBd8MEAE&adk=2374356963&tt=-1&bs=1585%2C1200&mtos=1065,1065,1065,1065,1065&tos=1065,0,0,0,0&p=305,1052.5,555,1352.5&mcvt=1065&rs=3&ht=0&tfs=129&tls=1194&mc=1&lte=1&bas=0&bac=0&met=0&avms=nio&niot_obs=12&niot_cbk=21&md=2&rst=1566793881031&rpt=326&isd=0&msd=0&lm=2&oseid=3&xdi=0&ps=1585%2C3683&ss=1600%2C1200&pt=-1&bin=1&deb=1-4-4-12-13-16-53-11-0-0-0&tvt=1186&r=v&id=osdim&vs=4&uc=12&upc=11&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=300x250&itpl=3&v=20190823

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.66 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s25-in-f2.1e100.net

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:22 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
status: 200
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin: *
cache-control: no-cache, must-revalidate
content-type: image/gif
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 activeview
pagead2.googlesyndication.com/pcs/ Frame 3EE9 42 B
110 B 43ms
43ms Image
image/gif 216.58.207.66
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstBzQlUBfubb5DdvdeLIiwuFMmFD1TftNKw4YYNF6h1s6f9W4Ar4hLgUMPAt3a5EvIS01EzwpvwQChxpXEHcnk2CniV9ubL1kt4YAOFIB4&sig=Cg0ArKJSzJE6OX9XcfJ-EAE&adk=2198966543&tt=-1&bs=1585%2C1200&mtos=1065,1065,1065,1065,1065&tos=1065,0,0,0,0&p=826,1052.5,1076,1352.5&mcvt=1065&rs=3&ht=0&tfs=129&tls=1194&mc=1&lte=1&bas=0&bac=0&met=0&avms=nio&niot_obs=12&niot_cbk=21&md=2&rst=1566793881273&rpt=44&isd=0&msd=0&lm=2&oseid=3&xdi=0&ps=1585%2C3683&ss=1600%2C1200&pt=-1&bin=1&deb=1-4-4-12-13-16-53-11-0-0-0&tvt=1186&r=v&id=osdim&vs=4&uc=12&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=300x250&itpl=3&v=20190823

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.207.66 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

fra16s25-in-f2.1e100.net

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Sec-Fetch-Mode: no-cors
Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:22 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
status: 200
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin: *
cache-control: no-cache, must-revalidate
content-type: image/gif
alt-svc: quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2

200

ga-audiences
www.google.de/ads/
Redirect Chain

https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1307723831&t=event&ni=0&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivaca...
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1510935939.1566793877&jid=1153770094&_gid=1626426807.1566793888&gjid=554820119&_v=j79&z=284972382
https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1510935939.1566793877&jid=1153770094&_v=j79&z=284972382
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1510935939.1566793877&jid=1153770094&_v=j79&z=284972382&slf_rd=1&random=3646715837

42 B
109 B

17ms
17ms

Image
image/gif

2a00:1450:4001:821::2003
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1510935939.1566793877&jid=1153770094&_v=j79&z=284972382&slf_rd=1&random=3646715837

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:821::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:27 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
cache-control: no-cache, no-store, must-revalidate
content-type: image/gif
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:27 GMT
x-content-type-options: nosniff
server: cafe
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 302
content-type: text/html; charset=UTF-8
location: https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1510935939.1566793877&jid=1153770094&_v=j79&z=284972382&slf_rd=1&random=3646715837
cache-control: no-cache, no-store, must-revalidate
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 0
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2

200

ga-audiences
www.google.de/ads/
Redirect Chain

https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1307723831&t=event&ni=0&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivaca...
https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1510935939.1566793877&jid=908817938&_gid=1185070622.1566793903&gjid=1340627042&_v=j79&z=1083985752
https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1510935939.1566793877&jid=908817938&_v=j79&z=1083985752
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1510935939.1566793877&jid=908817938&_v=j79&z=1083985752&slf_rd=1&random=2767011988

42 B
109 B

19ms
19ms

Image
image/gif

2a00:1450:4001:81d::2003
Google LLC

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1510935939.1566793877&jid=908817938&_v=j79&z=1083985752&slf_rd=1&random=2767011988

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-hay-20190826&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-65947-2303653
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:42 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
cache-control: no-cache, no-store, must-revalidate
content-type: image/gif
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma: no-cache
date: Mon, 26 Aug 2019 04:31:42 GMT
x-content-type-options: nosniff
server: cafe
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 302
content-type: text/html; charset=UTF-8
location: https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1510935939.1566793877&jid=908817938&_v=j79&z=1083985752&slf_rd=1&random=2767011988
cache-control: no-cache, no-store, must-revalidate
timing-allow-origin: *
alt-svc: quic=":443"; ma=2592000; v="46,43,39"
content-length: 0
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain: mpct1.maropost.com
URL: https://mpct1.maropost.com/accounts/1323/websites/5/track/96ac8580a54c3864c4ba15ff4a38efdcb7084985.js?contact_id=2303653&campaign_id=65947&title=FDA%20to%20Review%20Elexacaftor%2C%20Tezacaftor%2C%20Ivacaftor%20Combo%20for%20Cystic%20Fibrosis%20-%20MPR&url=https%3A%2F%2Fempr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ffda-to-review-elexacaftor-tezacaftor-ivacaftor-combo-for-cystic-fibrosis%2F&parent_url=&version=2&&&&funnel[0][name]=&funnel[0][status]=started&funnel[0][time_out]=40&

Domain: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12

Domain: ml314.com
URL: https://ml314.com/tag.aspx?2672019

Domain: d31qbv1cthcecs.cloudfront.net
URL: https://d31qbv1cthcecs.cloudfront.net/atrk.js

Domain: mt.sitomobile.com
URL: https://mt.sitomobile.com/sync/ta?aid=136&sid=hmm&val=12

Domain: js.adsrvr.org
URL: https://js.adsrvr.org/up_loader.1.1.0.js

Domain: subapi.haymarketmedia.com
URL: https://subapi.haymarketmedia.com/newsletter/13

Domain: subapi.haymarketmedia.com
URL: https://subapi.haymarketmedia.com/newsletter/13

Domain: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html

Domain: ads.spotible.com
URL: https://ads.spotible.com/tag/universal-tag.js

Verdicts & Comments Add Verdict or Comment

166 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

0 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

2 Console Messages

A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.

Source	Level	URL Text
console-api	log	URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1(Line 2) Message: JQMIGRATE: Migrate is installed, version 1.4.1
console-api	log	URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js(Line 540) Message: interactive

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
accounts.haymarketmedia.com
ads.spotible.com
adservice.google.com
adservice.google.de
adtrackapi.haymarketmedia.com
api-34-210-86-189.b2c.com
api-54-218-116-18.b2c.com
api.b2c.com
api.lytics.io
c.lytics.io
connect.facebook.net
content.maropost.com
d31qbv1cthcecs.cloudfront.net
fonts.googleapis.com
fonts.gstatic.com
js.adsrvr.org
link.email.empr.com
ml314.com
mpct1.maropost.com
mt.sitomobile.com
pagead2.googlesyndication.com
s3.amazonaws.com
sb.scorecardresearch.com
script.crazyegg.com
securepubads.g.doubleclick.net
stats.g.doubleclick.net
subapi.haymarketmedia.com
tags.crwdcntrl.net
tpc.googlesyndication.com
www.empr.com
www.endocrinologyadvisor.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.infectiousdiseaseadvisor.com
www.medtargetsystem.com
ads.spotible.com
d31qbv1cthcecs.cloudfront.net
js.adsrvr.org
ml314.com
mpct1.maropost.com
mt.sitomobile.com
subapi.haymarketmedia.com
tpc.googlesyndication.com
www.medtargetsystem.com
104.111.214.103
216.58.207.34
216.58.207.66
2600:1f14:e96:5800:bf44:2e7b:f554:ed7b
2600:1f14:e96:5800:e914:8d8d:e7fd:f63e
2600:1f14:e96:5802:dbba:9f1a:1862:a442
2600:9000:2057:1e00:16:bc48:4dc0:93a1
2600:9000:2057:5c00:1b:fadc:b780:93a1
2606:4700:20::6819:5365
2606:4700::6813:9308
2a00:1450:4001:806::2001
2a00:1450:4001:808::2002
2a00:1450:4001:816::2003
2a00:1450:4001:818::2002
2a00:1450:4001:81a::2008
2a00:1450:4001:81a::200e
2a00:1450:4001:81d::2003
2a00:1450:4001:81f::200a
2a00:1450:4001:820::2004
2a00:1450:4001:821::2003
2a00:1450:400c:c00::9a
2a00:1450:400c:c00::9b
2a03:2880:f01c:8012:face:b00c:0:3
2a03:2880:f11c:8083:face:b00c:0:25de
3.225.154.29
34.210.86.189
35.174.96.0
35.227.192.113
35.238.92.4
52.216.206.253
54.218.116.18
93.184.220.113
94.31.29.64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www.empr.com Open in urlscan Pro 3.225.154.29 Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page URL History Show full URLs

Detected technologies

Page Statistics

211 Requests

95 %HTTPS

64 %IPv6

29 Domains

40 Subdomains

31 IPs

6 Countries

6789 kBTransfer

8931 kBSize

0 Cookies

34 Outgoing links

Page URL History

Redirected requests

211 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 7 data transactions

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

www.empr.com Open in urlscan Pro
3.225.154.29 Public Scan

Screenshot
Live screenshot

Full Image

211
Requests

95 %
HTTPS

64 %
IPv6

29
Domains

40
Subdomains

31
IPs

6
Countries

6789 kB
Transfer

8931 kB
Size

0
Cookies

211 HTTP transactions
7 data transactions